[
  {
    "bcr_patient_uuid": "fc222f23-b3b2-4ac0-bc61-e8e8fa5cc160",
    "patient_ID": "TCGA.CS.4941",
    "bcr_drug_barcode": "TCGA-CS-4941-D19325",
    "bcr_drug_uuid": "5fa9ba75-3196-4fba-a773-77e500473c2f",
    "form_completion_date": "2011-12-8",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "230f5fa7-aa36-41ea-b40b-08f520767bd5",
    "patient_ID": "TCGA.CS.4942",
    "bcr_drug_barcode": "TCGA-CS-4942-D17619",
    "bcr_drug_uuid": "c4d4f444-f628-43f4-8983-ff68f99b4bb0",
    "form_completion_date": "2011-10-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1241,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1260,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "952dfd5d-e65a-4307-b6a9-2ed2b0d2d9ce",
    "patient_ID": "TCGA.CS.4943",
    "bcr_drug_barcode": "TCGA-CS-4943-D10215",
    "bcr_drug_uuid": "442c5dd3-d3e9-4c63-8979-b2db1ad4b768",
    "form_completion_date": "2011-4-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 408,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c6cf2b8e-40ed-4c9f-8419-d868bd5afe11",
    "patient_ID": "TCGA.CS.5390",
    "bcr_drug_barcode": "TCGA-CS-5390-D15570",
    "bcr_drug_uuid": "db6ba6a3-3a44-4ecb-919e-282d78f1412a",
    "form_completion_date": "2011-8-25",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 886,
    "drug_units": "MG",
    "drug_dose": 300,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e8d3d888-e5fc-4469-ad0b-2c1df6e04790",
    "patient_ID": "TCGA.CS.5393",
    "bcr_drug_barcode": "TCGA-CS-5393-D15814",
    "bcr_drug_uuid": "a037675e-cddc-4cdd-ab75-9221e715ca61",
    "form_completion_date": "2011-8-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f86fa219-34e9-4812-8edf-2b66d7219779",
    "patient_ID": "TCGA.CS.5395",
    "bcr_drug_barcode": "TCGA-CS-5395-D10076",
    "bcr_drug_uuid": "f6605382-bfa1-4648-bbe1-4da6295aa7a8",
    "form_completion_date": "2011-3-13",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 579,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 980,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10780
  },
  {
    "bcr_patient_uuid": "f86fa219-34e9-4812-8edf-2b66d7219779",
    "patient_ID": "TCGA.CS.5395",
    "bcr_drug_barcode": "TCGA-CS-5395-D19845",
    "bcr_drug_uuid": "135a69bd-6cdb-45f9-b1d7-f698b8fea52a",
    "form_completion_date": "2011-12-29",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 259,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b6c2c9bd-625b-4a98-830c-49c344f6cb5f",
    "patient_ID": "TCGA.CS.5396",
    "bcr_drug_barcode": "TCGA-CS-5396-D15818",
    "bcr_drug_uuid": "7b80fb67-5c9f-4889-bab8-a973e53717f1",
    "form_completion_date": "2011-9-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bdfade49-9059-4665-beea-c55117ba6564",
    "patient_ID": "TCGA.CS.5397",
    "bcr_drug_barcode": "TCGA-CS-5397-D17569",
    "bcr_drug_uuid": "884d36f1-3c32-4867-8f9f-9f0421d6362b",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ee6e821-3af2-42d7-9d14-f0ca455f338c",
    "patient_ID": "TCGA.CS.6186",
    "bcr_drug_barcode": "TCGA-CS-6186-D18645",
    "bcr_drug_uuid": "0799781a-105d-437e-afb2-6381b42c5e39",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9ee6e821-3af2-42d7-9d14-f0ca455f338c",
    "patient_ID": "TCGA.CS.6186",
    "bcr_drug_barcode": "TCGA-CS-6186-D18648",
    "bcr_drug_uuid": "dd8b100d-1cdd-436e-af4e-d2b268c97f3c",
    "form_completion_date": "2011-11-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 512,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 840,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "3f70c3e3-0131-466f-92aa-0a63ab3d4258",
    "patient_ID": "TCGA.CS.6188",
    "bcr_drug_barcode": "TCGA-CS-6188-D17678",
    "bcr_drug_uuid": "0d299bff-323c-4529-b028-86571ff11176",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 716,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42fe260f-520b-4fac-8c09-d2b31aed59fb",
    "patient_ID": "TCGA.CS.6290",
    "bcr_drug_barcode": "TCGA-CS-6290-D17566",
    "bcr_drug_uuid": "4b47d8fe-0c26-4476-9676-c2bcc77004ec",
    "form_completion_date": "2011-10-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 504,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c16d9f69-26f9-4ec7-b2d5-ff9f7dacfe0f",
    "patient_ID": "TCGA.CS.6665",
    "bcr_drug_barcode": "TCGA-CS-6665-D17574",
    "bcr_drug_uuid": "c3b5ee73-099a-47c3-abb8-c0dcca5e0033",
    "form_completion_date": "2011-10-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8cba230b-46db-4d35-8123-3879eba32402",
    "patient_ID": "TCGA.CS.6666",
    "bcr_drug_barcode": "TCGA-CS-6666-D17578",
    "bcr_drug_uuid": "e4bada7d-4627-43bb-9c13-8188395833ad",
    "form_completion_date": "2011-9-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a5d3f3fb-6541-419d-b47e-720d438f1bff",
    "patient_ID": "TCGA.CS.6668",
    "bcr_drug_barcode": "TCGA-CS-6668-D17586",
    "bcr_drug_uuid": "ae31a013-3c31-42fe-9b59-da0d0280a6fc",
    "form_completion_date": "2011-9-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc5bdd21-b23f-400e-bbe2-4c98a517fc9e",
    "patient_ID": "TCGA.CS.6669",
    "bcr_drug_barcode": "TCGA-CS-6669-D17590",
    "bcr_drug_uuid": "3f8e0599-a4ec-47cd-8894-5db97c17437c",
    "form_completion_date": "2011-9-24",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "60b30a95-3e4c-413a-9de6-16a5bca163c4",
    "patient_ID": "TCGA.CS.6670",
    "bcr_drug_barcode": "TCGA-CS-6670-D19946",
    "bcr_drug_uuid": "99349bbe-c046-49b0-a59f-b228a4426aae",
    "form_completion_date": "2012-1-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "60b30a95-3e4c-413a-9de6-16a5bca163c4",
    "patient_ID": "TCGA.CS.6670",
    "bcr_drug_barcode": "TCGA-CS-6670-D19944",
    "bcr_drug_uuid": "25b4ae45-fb44-43d8-8cf3-95b10f64f46c",
    "form_completion_date": "2012-1-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -325,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -227,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 5000
  },
  {
    "bcr_patient_uuid": "60b30a95-3e4c-413a-9de6-16a5bca163c4",
    "patient_ID": "TCGA.CS.6670",
    "bcr_drug_barcode": "TCGA-CS-6670-D19945",
    "bcr_drug_uuid": "ac52a959-5315-4264-9d65-a69cafb15e1a",
    "form_completion_date": "2012-1-5",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -30,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "b7cd3b44-ef6a-4207-a44f-14f5b3b56ed4",
    "patient_ID": "TCGA.DB.5270",
    "bcr_drug_barcode": "TCGA-DB-5270-D14213",
    "bcr_drug_uuid": "8ec0b3e1-0428-4a80-97a0-39638ce7d944",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 761,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 917,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "ae2db022-eb4f-4b65-89b6-9fd4439ddeef",
    "patient_ID": "TCGA.DB.5273",
    "bcr_drug_barcode": "TCGA-DB-5273-D14441",
    "bcr_drug_uuid": "550b69bc-23b1-44c5-be57-7ecb3c5808a7",
    "form_completion_date": "2011-7-00",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 302,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12450
  },
  {
    "bcr_patient_uuid": "ae2db022-eb4f-4b65-89b6-9fd4439ddeef",
    "patient_ID": "TCGA.DB.5273",
    "bcr_drug_barcode": "TCGA-DB-5273-D14250",
    "bcr_drug_uuid": "0639f52e-b0e8-4d1f-b84f-1f89647234c7",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "0b54cda4-7568-481e-b0c6-2c5c6de0026c",
    "patient_ID": "TCGA.DB.5274",
    "bcr_drug_barcode": "TCGA-DB-5274-D14422",
    "bcr_drug_uuid": "9f32c049-4894-4377-a066-ae609c40a0ef",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10800
  },
  {
    "bcr_patient_uuid": "0b54cda4-7568-481e-b0c6-2c5c6de0026c",
    "patient_ID": "TCGA.DB.5274",
    "bcr_drug_barcode": "TCGA-DB-5274-D14421",
    "bcr_drug_uuid": "c7e43fb6-4054-47f5-b360-9c8c0357383e",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5670
  },
  {
    "bcr_patient_uuid": "bbfb5399-8d43-4b75-bf90-23ec142697d7",
    "patient_ID": "TCGA.DB.5275",
    "bcr_drug_barcode": "TCGA-DB-5275-D14426",
    "bcr_drug_uuid": "e91c5836-1333-44d8-960e-24db52d231d9",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "bbfb5399-8d43-4b75-bf90-23ec142697d7",
    "patient_ID": "TCGA.DB.5275",
    "bcr_drug_barcode": "TCGA-DB-5275-D14430",
    "bcr_drug_uuid": "cb6f0480-725d-4ef7-979e-e0f5799383bd",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 359,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "9d0c1552-00a7-4f0a-a04a-a82e721ee4e3",
    "patient_ID": "TCGA.DB.5276",
    "bcr_drug_barcode": "TCGA-DB-5276-D14435",
    "bcr_drug_uuid": "cf5efc36-9230-4008-a50c-1f5d89ca5c64",
    "form_completion_date": "2011-7-00",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "9d0c1552-00a7-4f0a-a04a-a82e721ee4e3",
    "patient_ID": "TCGA.DB.5276",
    "bcr_drug_barcode": "TCGA-DB-5276-D14433",
    "bcr_drug_uuid": "d0517edd-ec4b-4404-a060-e8fe19782140",
    "form_completion_date": "2011-7-00",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6510
  },
  {
    "bcr_patient_uuid": "9d0c1552-00a7-4f0a-a04a-a82e721ee4e3",
    "patient_ID": "TCGA.DB.5276",
    "bcr_drug_barcode": "TCGA-DB-5276-D15527",
    "bcr_drug_uuid": "9509ff37-b028-4b82-8039-a62706ff87c8",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1196,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "9d0c1552-00a7-4f0a-a04a-a82e721ee4e3",
    "patient_ID": "TCGA.DB.5276",
    "bcr_drug_barcode": "TCGA-DB-5276-D15525",
    "bcr_drug_uuid": "a0a1954b-de5b-479d-92f5-dcab0a809a1d",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1189,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 600,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "d05079f2-9883-46e6-ad06-9e561f08d819",
    "patient_ID": "TCGA.DB.5277",
    "bcr_drug_barcode": "TCGA-DB-5277-D14419",
    "bcr_drug_uuid": "b8d13d9f-90f4-43c2-b5fc-2f55941c5b20",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "drug_cycles": 5,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5250
  },
  {
    "bcr_patient_uuid": "d05079f2-9883-46e6-ad06-9e561f08d819",
    "patient_ID": "TCGA.DB.5277",
    "bcr_drug_barcode": "TCGA-DB-5277-D14420",
    "bcr_drug_uuid": "cbc335aa-955f-443f-b8db-b8466075d2e3",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 361,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9900
  },
  {
    "bcr_patient_uuid": "d05079f2-9883-46e6-ad06-9e561f08d819",
    "patient_ID": "TCGA.DB.5277",
    "bcr_drug_barcode": "TCGA-DB-5277-D15524",
    "bcr_drug_uuid": "9adc1973-ccc6-446b-a88e-66582277fa98",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1239,
    "drug_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "15a6ad18-a81c-4f5b-80ae-ef56ccf722f9",
    "patient_ID": "TCGA.DB.5281",
    "bcr_drug_barcode": "TCGA-DB-5281-D14439",
    "bcr_drug_uuid": "e7a75c37-6dc9-4fce-8b89-f4421fbc89c1",
    "form_completion_date": "2011-7-00",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "15a6ad18-a81c-4f5b-80ae-ef56ccf722f9",
    "patient_ID": "TCGA.DB.5281",
    "bcr_drug_barcode": "TCGA-DB-5281-D14437",
    "bcr_drug_uuid": "dbd42c32-58ee-4ce6-a5fa-26fabdb20c19",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "FB6437F9-ADE8-4C33-A0D0-CEACB2BF784D",
    "patient_ID": "TCGA.DB.A4XB",
    "bcr_drug_barcode": "TCGA-DB-A4XB-D40508",
    "bcr_drug_uuid": "49B0E615-ABFF-4D27-B8E9-50F9544D9EAA",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1BFF1E07-4923-43D5-B2D3-CB46B6568EED",
    "patient_ID": "TCGA.DB.A4XD",
    "bcr_drug_barcode": "TCGA-DB-A4XD-D40472",
    "bcr_drug_uuid": "031BBEB5-469C-4856-AB64-13746690D8E2",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 291,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "40587B69-0F62-4A2A-88CB-1BD711377F19",
    "patient_ID": "TCGA.DB.A4XF",
    "bcr_drug_barcode": "TCGA-DB-A4XF-D40479",
    "bcr_drug_uuid": "C06C881C-FE44-474B-84FC-132007A2C22A",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7704E4A8-C7AA-4288-B1ED-68C23ABBE924",
    "patient_ID": "TCGA.DB.A4XG",
    "bcr_drug_barcode": "TCGA-DB-A4XG-D40491",
    "bcr_drug_uuid": "4D136088-CEE6-415F-B6C4-EE9883EF46A0",
    "form_completion_date": "2013-2-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1732,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2067,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0536F465-1650-4411-823C-C660BC7F3ADC",
    "patient_ID": "TCGA.DB.A64O",
    "bcr_drug_barcode": "TCGA-DB-A64O-D46423",
    "bcr_drug_uuid": "D1E2E600-66EC-46FA-8AFB-930AD71BBE58",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 461,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 551,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "12F02422-585D-4068-BBDE-BC279C6A89AB",
    "patient_ID": "TCGA.DB.A64P",
    "bcr_drug_barcode": "TCGA-DB-A64P-D46428",
    "bcr_drug_uuid": "E56A1559-9641-454E-9F14-ED00F645D89E",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "887DEF39-E212-490D-8849-2BC932FCEFF0",
    "patient_ID": "TCGA.DB.A64Q",
    "bcr_drug_barcode": "TCGA-DB-A64Q-D46483",
    "bcr_drug_uuid": "016B428B-6EFC-4316-AE5C-9575AB2885A2",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "176D89D7-F8F1-4A72-B45A-31CBE1632A30",
    "patient_ID": "TCGA.DB.A64V",
    "bcr_drug_barcode": "TCGA-DB-A64V-D46511",
    "bcr_drug_uuid": "DACF8EBF-D304-4805-901B-8D708EBB040A",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 330,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DF22BC30-96E2-42DE-9A39-2954DB49841D",
    "patient_ID": "TCGA.DB.A64W",
    "bcr_drug_barcode": "TCGA-DB-A64W-D46509",
    "bcr_drug_uuid": "07E285BC-D322-4AB9-8083-F1F3F64A2814",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9922DE10-9280-44C0-B86F-6D1CA7E55BF2",
    "patient_ID": "TCGA.DB.A64X",
    "bcr_drug_barcode": "TCGA-DB-A64X-D46516",
    "bcr_drug_uuid": "640A29D8-5081-47AA-93FE-06A3B488486E",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F853A88-811D-4EB4-914E-D90862C5D2A2",
    "patient_ID": "TCGA.DB.A75K",
    "bcr_drug_barcode": "TCGA-DB-A75K-D56207",
    "bcr_drug_uuid": "9F88DDF4-2335-4239-AD47-2B1C42645364",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA62B5EB-E169-4B41-B949-E004D66E98A1",
    "patient_ID": "TCGA.DB.A75L",
    "bcr_drug_barcode": "TCGA-DB-A75L-D56226",
    "bcr_drug_uuid": "4A9963F5-D17C-456A-8750-B7246AC188A0",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0709DBCC-0828-4066-AA01-96F059E5FA97",
    "patient_ID": "TCGA.DB.A75M",
    "bcr_drug_barcode": "TCGA-DB-A75M-D56231",
    "bcr_drug_uuid": "18A2D014-E215-4CAC-BA38-A9A84289DF04",
    "form_completion_date": "2014-1-30",
    "pharmaceutical_therapy_drug_name": "CDR0000654697",
    "clinical_trial_drug_classification": "E3FO5",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2c03e8b9-8856-43a7-853d-5ec51a6e5330",
    "patient_ID": "TCGA.DH.5140",
    "bcr_drug_barcode": "TCGA-DH-5140-D6486",
    "bcr_drug_uuid": "ee3a53f2-38a0-413a-bede-f2536de84d7e",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3375
  },
  {
    "bcr_patient_uuid": "2c03e8b9-8856-43a7-853d-5ec51a6e5330",
    "patient_ID": "TCGA.DH.5140",
    "bcr_drug_barcode": "TCGA-DH-5140-D6488",
    "bcr_drug_uuid": "fb9a572a-d724-4ef3-9bc4-857e31e85406",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "BCNU (CARMUSTINE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 342,
    "drug_cycles": 2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2c03e8b9-8856-43a7-853d-5ec51a6e5330",
    "patient_ID": "TCGA.DH.5140",
    "bcr_drug_barcode": "TCGA-DH-5140-D6487",
    "bcr_drug_uuid": "2528c43a-9af2-43f6-8c9d-e3e5749fdf41",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/KG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "2c03e8b9-8856-43a7-853d-5ec51a6e5330",
    "patient_ID": "TCGA.DH.5140",
    "bcr_drug_barcode": "TCGA-DH-5140-D6489",
    "bcr_drug_uuid": "8e430c37-8406-47f8-a618-2744c8b542a1",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "AT 101",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2cf49bac-dea1-45ff-9e1d-09f5a2ac5215",
    "patient_ID": "TCGA.DH.5141",
    "bcr_drug_barcode": "TCGA-DH-5141-D6516",
    "bcr_drug_uuid": "d266f15b-21b0-4d1a-9585-36f36703aead",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 890,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 936,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2cf49bac-dea1-45ff-9e1d-09f5a2ac5215",
    "patient_ID": "TCGA.DH.5141",
    "bcr_drug_barcode": "TCGA-DH-5141-D6519",
    "bcr_drug_uuid": "b304c8a9-f632-4a44-8e84-83cc51ce5600",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5b744051-7355-4e15-b035-0621e709a5d7",
    "patient_ID": "TCGA.DH.5142",
    "bcr_drug_barcode": "TCGA-DH-5142-D6544",
    "bcr_drug_uuid": "91998a7d-11c1-427d-b99b-db9ef95ed478",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "5b744051-7355-4e15-b035-0621e709a5d7",
    "patient_ID": "TCGA.DH.5142",
    "bcr_drug_barcode": "TCGA-DH-5142-D6545",
    "bcr_drug_uuid": "9111add0-24dc-4c01-9713-7daf44bd49a3",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 400,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 480,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5280
  },
  {
    "bcr_patient_uuid": "5b744051-7355-4e15-b035-0621e709a5d7",
    "patient_ID": "TCGA.DH.5142",
    "bcr_drug_barcode": "TCGA-DH-5142-D6543",
    "bcr_drug_uuid": "b983b0e5-76b1-4c94-90ec-c9f65f430202",
    "form_completion_date": "2010-12-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "dcd0856d-423a-40d7-8070-4c0988d61416",
    "patient_ID": "TCGA.DH.5143",
    "bcr_drug_barcode": "TCGA-DH-5143-D6554",
    "bcr_drug_uuid": "e0609dd7-caf7-4d71-8d16-a6c8fc349c69",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "dcd0856d-423a-40d7-8070-4c0988d61416",
    "patient_ID": "TCGA.DH.5143",
    "bcr_drug_barcode": "TCGA-DH-5143-D6555",
    "bcr_drug_uuid": "aea492a1-1963-4067-9bee-cd18fbd03c79",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "dcd0856d-423a-40d7-8070-4c0988d61416",
    "patient_ID": "TCGA.DH.5143",
    "bcr_drug_barcode": "TCGA-DH-5143-D6557",
    "bcr_drug_uuid": "61b753cb-378d-471f-a6fa-1d534eeaa3d3",
    "form_completion_date": "2010-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 12,
    "drug_units": "MG/M2/DAY",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "CB1E9916-C03F-405A-A797-15823DF09C8E",
    "patient_ID": "TCGA.DH.A66B",
    "bcr_drug_barcode": "TCGA-DH-A66B-D46562",
    "bcr_drug_uuid": "9A60312E-9D6E-4C6A-A773-1DD195DBA56E",
    "form_completion_date": "2013-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 432,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F005FA99-7E4E-4308-B11C-83B25683B1FD",
    "patient_ID": "TCGA.DH.A66D",
    "bcr_drug_barcode": "TCGA-DH-A66D-D46564",
    "bcr_drug_uuid": "DEF7727B-93B0-4931-BF66-027EB013CC90",
    "form_completion_date": "2013-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DA40E6D3-A2A9-4517-AAA2-AEF6C3892EBF",
    "patient_ID": "TCGA.DH.A66G",
    "bcr_drug_barcode": "TCGA-DH-A66G-D64430",
    "bcr_drug_uuid": "E9553E2D-EAF0-48AD-979F-23ECA9666C61",
    "form_completion_date": "2014-9-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B37ABDC8-B9E3-4F1A-B16D-2E59442DB335",
    "patient_ID": "TCGA.DH.A7UR",
    "bcr_drug_barcode": "TCGA-DH-A7UR-D60282",
    "bcr_drug_uuid": "7500051C-55B3-465A-8FFA-30EED95ABD8B",
    "form_completion_date": "2014-6-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1076,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B2B57E93-2722-4546-9A0B-20155B86EDEF",
    "patient_ID": "TCGA.DH.A7UT",
    "bcr_drug_barcode": "TCGA-DH-A7UT-D60292",
    "bcr_drug_uuid": "AF34A876-4053-4F16-AFEF-058D051E29BA",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "977118C8-B446-4696-AA6E-9F1A1055E241",
    "patient_ID": "TCGA.DH.A7UU",
    "bcr_drug_barcode": "TCGA-DH-A7UU-D60354",
    "bcr_drug_uuid": "6B976447-B1E6-4CC4-A0A5-D25E373C2671",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3B19B5D1-13AF-4669-A082-1BD546048185",
    "patient_ID": "TCGA.DH.A7UV",
    "bcr_drug_barcode": "TCGA-DH-A7UV-D60356",
    "bcr_drug_uuid": "23F803F1-9471-463E-B2A5-74C49E3A765A",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 463,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "92a7c445-2217-400a-bdcd-df41502416b6",
    "patient_ID": "TCGA.DU.5847",
    "bcr_drug_barcode": "TCGA-DU-5847-D14829",
    "bcr_drug_uuid": "a3b7d452-71cd-4e89-a6ef-48dd6d15b804",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "92a7c445-2217-400a-bdcd-df41502416b6",
    "patient_ID": "TCGA.DU.5847",
    "bcr_drug_barcode": "TCGA-DU-5847-D14827",
    "bcr_drug_uuid": "3af6c9cd-f9b6-4671-a6fd-6ebfc1699b25",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "92a7c445-2217-400a-bdcd-df41502416b6",
    "patient_ID": "TCGA.DU.5847",
    "bcr_drug_barcode": "TCGA-DU-5847-D14830",
    "bcr_drug_uuid": "55c779f0-e61a-473c-8a89-935f50562c9a",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5af8ada5-86b5-4832-8a8e-e975ecca5515",
    "patient_ID": "TCGA.DU.5849",
    "bcr_drug_barcode": "TCGA-DU-5849-D14890",
    "bcr_drug_uuid": "265ff908-1f73-4a94-9166-64c735e61e58",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "55c78413-d102-4113-930e-6d842862fe75",
    "patient_ID": "TCGA.DU.5851",
    "bcr_drug_barcode": "TCGA-DU-5851-D15074",
    "bcr_drug_uuid": "1bff07b5-b100-4dc9-be59-bfeabebe8eaa",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "55c78413-d102-4113-930e-6d842862fe75",
    "patient_ID": "TCGA.DU.5851",
    "bcr_drug_barcode": "TCGA-DU-5851-D15073",
    "bcr_drug_uuid": "b08d6a07-2ac8-4949-adf8-26d8bab2f154",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "9ed5af0e-c87f-46ff-81e7-9d3041b4034e",
    "patient_ID": "TCGA.DU.5852",
    "bcr_drug_barcode": "TCGA-DU-5852-D17046",
    "bcr_drug_uuid": "37497c94-f7b5-4748-9413-bd374ef59b97",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2d42dd0e-be3a-46ae-a635-c6f9c52f9fa2",
    "patient_ID": "TCGA.DU.5853",
    "bcr_drug_barcode": "TCGA-DU-5853-D16883",
    "bcr_drug_uuid": "dda7fbcd-163a-4afe-b64b-e6d76c7c3552",
    "form_completion_date": "2011-9-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "b95afb1a-a1df-4d85-ad34-191928e28a77",
    "patient_ID": "TCGA.DU.5854",
    "bcr_drug_barcode": "TCGA-DU-5854-D14895",
    "bcr_drug_uuid": "3457f389-62db-4528-b1fb-9a1470be12f7",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "b95afb1a-a1df-4d85-ad34-191928e28a77",
    "patient_ID": "TCGA.DU.5854",
    "bcr_drug_barcode": "TCGA-DU-5854-D14896",
    "bcr_drug_uuid": "ae61433b-1ffa-476f-9a1e-4c4301ae7c53",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "b95afb1a-a1df-4d85-ad34-191928e28a77",
    "patient_ID": "TCGA.DU.5854",
    "bcr_drug_barcode": "TCGA-DU-5854-D14897",
    "bcr_drug_uuid": "3f5bab65-4c76-47ee-9c6e-ba279e02acc9",
    "form_completion_date": "2011-6-22",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 850
  },
  {
    "bcr_patient_uuid": "e326c1dd-2ef8-431b-a657-440aa3f35ff3",
    "patient_ID": "TCGA.DU.5855",
    "bcr_drug_barcode": "TCGA-DU-5855-D14806",
    "bcr_drug_uuid": "8fda500e-bf37-490b-816b-b3bac86f6197",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "e326c1dd-2ef8-431b-a657-440aa3f35ff3",
    "patient_ID": "TCGA.DU.5855",
    "bcr_drug_barcode": "TCGA-DU-5855-D14805",
    "bcr_drug_uuid": "0917cb19-d74a-4fb8-8750-5709eec75033",
    "form_completion_date": "2011-5-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "eb42625e-fbbb-4bee-bbe9-315b3ca2138a",
    "patient_ID": "TCGA.DU.5870",
    "bcr_drug_barcode": "TCGA-DU-5870-D14723",
    "bcr_drug_uuid": "d81e218d-faf8-4926-9cbb-bc8f97033156",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4500,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4543,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "eb42625e-fbbb-4bee-bbe9-315b3ca2138a",
    "patient_ID": "TCGA.DU.5870",
    "bcr_drug_barcode": "TCGA-DU-5870-D14733",
    "bcr_drug_uuid": "ea48cccb-3567-41ba-868f-0f3ffa507732",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4536,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4901,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 230
  },
  {
    "bcr_patient_uuid": "ddfd76dc-15d6-4efc-85ea-31674161ebf3",
    "patient_ID": "TCGA.DU.5871",
    "bcr_drug_barcode": "TCGA-DU-5871-D14695",
    "bcr_drug_uuid": "23026c9a-3af3-475a-a74f-4a6ca91d1c66",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "ddfd76dc-15d6-4efc-85ea-31674161ebf3",
    "patient_ID": "TCGA.DU.5871",
    "bcr_drug_barcode": "TCGA-DU-5871-D14696",
    "bcr_drug_uuid": "9ea9bdb9-1ae6-4eb4-8b30-74581a481d49",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "48607130-c09a-491d-882f-7d2591d13182",
    "patient_ID": "TCGA.DU.5872",
    "bcr_drug_barcode": "TCGA-DU-5872-D14773",
    "bcr_drug_uuid": "2e3322bc-a7d1-49c4-89f3-507124d59aac",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 155
  },
  {
    "bcr_patient_uuid": "48607130-c09a-491d-882f-7d2591d13182",
    "patient_ID": "TCGA.DU.5872",
    "bcr_drug_barcode": "TCGA-DU-5872-D14775",
    "bcr_drug_uuid": "212f0ee4-683e-426b-99f3-2ae9beadf05d",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 370,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 959
  },
  {
    "bcr_patient_uuid": "48607130-c09a-491d-882f-7d2591d13182",
    "patient_ID": "TCGA.DU.5872",
    "bcr_drug_barcode": "TCGA-DU-5872-D14776",
    "bcr_drug_uuid": "b3d8b5ea-bd0b-4738-ab53-d7aa88304b35",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 540,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "48607130-c09a-491d-882f-7d2591d13182",
    "patient_ID": "TCGA.DU.5872",
    "bcr_drug_barcode": "TCGA-DU-5872-D14774",
    "bcr_drug_uuid": "1772ca68-1a45-4fb5-a6f7-b5708225d9f3",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "1cc53ade-73c0-492b-a7dc-328269fd0e66",
    "patient_ID": "TCGA.DU.5874",
    "bcr_drug_barcode": "TCGA-DU-5874-D14707",
    "bcr_drug_uuid": "93cbb4cb-db7b-465a-a69d-69dbdf14397f",
    "form_completion_date": "2011-6-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "fcd9e1c4-bddb-4856-844c-03df48fba499",
    "patient_ID": "TCGA.DU.6392",
    "bcr_drug_barcode": "TCGA-DU-6392-D14730",
    "bcr_drug_uuid": "7ad5cb6c-01dc-4d48-bb9c-8745bb0f8a5b",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "fcd9e1c4-bddb-4856-844c-03df48fba499",
    "patient_ID": "TCGA.DU.6392",
    "bcr_drug_barcode": "TCGA-DU-6392-D14731",
    "bcr_drug_uuid": "6eddaf70-0f2e-433f-b5cd-36b4d14a8b6b",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1937318f-a1bb-4f48-b8ec-4aadd406e52a",
    "patient_ID": "TCGA.DU.6393",
    "bcr_drug_barcode": "TCGA-DU-6393-D14738",
    "bcr_drug_uuid": "9b11fdd3-35d1-4fd6-a51e-567c2ebb9f45",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 431,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42cc9620-98fb-4164-a3b2-28d084ca5a03",
    "patient_ID": "TCGA.DU.6394",
    "bcr_drug_barcode": "TCGA-DU-6394-D14766",
    "bcr_drug_uuid": "da2a97a2-bcd0-47dd-bd02-2f76d3e2fd75",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 278,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42cc9620-98fb-4164-a3b2-28d084ca5a03",
    "patient_ID": "TCGA.DU.6394",
    "bcr_drug_barcode": "TCGA-DU-6394-D14777",
    "bcr_drug_uuid": "1d863f0f-4a4c-4b5b-b142-3679d22bd91c",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 459,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "42cc9620-98fb-4164-a3b2-28d084ca5a03",
    "patient_ID": "TCGA.DU.6394",
    "bcr_drug_barcode": "TCGA-DU-6394-D14778",
    "bcr_drug_uuid": "42abc1ed-a79a-4973-843d-f35f70b1343e",
    "form_completion_date": "2011-5-27",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "6355cade-7b3a-43a8-9f1f-8e7bc45755a8",
    "patient_ID": "TCGA.DU.6395",
    "bcr_drug_barcode": "TCGA-DU-6395-D14947",
    "bcr_drug_uuid": "a3b4d4ea-fc08-47a3-80d6-c96e3f4a6cd1",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "6355cade-7b3a-43a8-9f1f-8e7bc45755a8",
    "patient_ID": "TCGA.DU.6395",
    "bcr_drug_barcode": "TCGA-DU-6395-D14946",
    "bcr_drug_uuid": "a6ce591e-8346-45ee-abee-715500c534e3",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1386,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6355cade-7b3a-43a8-9f1f-8e7bc45755a8",
    "patient_ID": "TCGA.DU.6395",
    "bcr_drug_barcode": "TCGA-DU-6395-D14944",
    "bcr_drug_uuid": "564bb929-f3d9-49eb-b544-286ac7cf8686",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 870,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1266,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14936",
    "bcr_drug_uuid": "406e2b57-e5a0-44cc-b65e-881ee8287f0f",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2250,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14939",
    "bcr_drug_uuid": "fa3ee205-f1c2-449a-bb8d-c7be90bb81a2",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "CAPECITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2250,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14931",
    "bcr_drug_uuid": "94427195-4e76-4498-8d14-caa0f65bd8f1",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "PCV",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14934",
    "bcr_drug_uuid": "27e77493-3706-4477-8dde-0f13bb5c3d05",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1762,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2188,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14932",
    "bcr_drug_uuid": "9a014511-a6fa-415d-94b6-e1b66bd06118",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "9 AMINOCAMPTOTHECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 636,
    "drug_cycles": 18,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 1611,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1611
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14933",
    "bcr_drug_uuid": "4cd94d5c-66be-4c9b-93ff-f46de4f44b15",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 915,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1062,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 125,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14930",
    "bcr_drug_uuid": "cd5425bf-34a2-4a3d-9fe1-dcf4c872d12a",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "BROMO DEOXYURIDINE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "pharma_type_other": "RADIOSENSITIZER",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "152eaa99-05f5-4d30-bfb1-494a9a900e49",
    "patient_ID": "TCGA.DU.6396",
    "bcr_drug_barcode": "TCGA-DU-6396-D14935",
    "bcr_drug_uuid": "1084ba3c-b0c8-4f60-ab84-83956e33cb8d",
    "form_completion_date": "2011-7-27",
    "pharmaceutical_therapy_drug_name": "ISOTRETINOIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1823,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1946,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e695b780-17f4-4e71-9120-7c6bcafaa3a7",
    "patient_ID": "TCGA.DU.6397",
    "bcr_drug_barcode": "TCGA-DU-6397-D14797",
    "bcr_drug_uuid": "92151a5e-0c57-4433-a49a-a714f5aa1cd7",
    "form_completion_date": "2011-5-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 884,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1219,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 325
  },
  {
    "bcr_patient_uuid": "97cb8701-7d63-4142-b404-006fbb3ecb0b",
    "patient_ID": "TCGA.DU.6401",
    "bcr_drug_barcode": "TCGA-DU-6401-D14755",
    "bcr_drug_uuid": "15e13b5e-7bc1-4492-9706-544b77b7d03c",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "SORAFENIB (BAY 43-9006)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2512,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2512,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "97cb8701-7d63-4142-b404-006fbb3ecb0b",
    "patient_ID": "TCGA.DU.6401",
    "bcr_drug_barcode": "TCGA-DU-6401-D14757",
    "bcr_drug_uuid": "455a61e4-9acc-4709-9dad-491b3c3bcc80",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2542,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2542,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "97cb8701-7d63-4142-b404-006fbb3ecb0b",
    "patient_ID": "TCGA.DU.6401",
    "bcr_drug_barcode": "TCGA-DU-6401-D14754",
    "bcr_drug_uuid": "d9b9efc4-14cf-4394-a70b-1117bea8d4d8",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1903,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2451,
    "drug_cycles": 16,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "152f028e-ee29-40e0-8e75-5cafffacbd45",
    "patient_ID": "TCGA.DU.6402",
    "bcr_drug_barcode": "TCGA-DU-6402-D14716",
    "bcr_drug_uuid": "3ae81b40-a276-4005-9c64-97ceaaedc041",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "8daa29c0-f652-4130-a004-5183bbe30c63",
    "patient_ID": "TCGA.DU.6403",
    "bcr_drug_barcode": "TCGA-DU-6403-D14746",
    "bcr_drug_uuid": "988b4562-6b54-445c-a85a-778d1d4a43a1",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8daa29c0-f652-4130-a004-5183bbe30c63",
    "patient_ID": "TCGA.DU.6403",
    "bcr_drug_barcode": "TCGA-DU-6403-D14748",
    "bcr_drug_uuid": "24ea3712-f7e6-417c-a7e2-777e6d70e4f7",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "BCNU (CARMUSTINE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8daa29c0-f652-4130-a004-5183bbe30c63",
    "patient_ID": "TCGA.DU.6403",
    "bcr_drug_barcode": "TCGA-DU-6403-D14747",
    "bcr_drug_uuid": "7ac56d66-1bea-479f-bce7-8039d1d1eb5c",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 10,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_dose": 1,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14786",
    "bcr_drug_uuid": "c45c5914-3f1a-44ef-8d3d-20ef29f2e583",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1762,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1967,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 325,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14798",
    "bcr_drug_uuid": "2128710b-2bfd-4200-a650-deb72ee4278c",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3227,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3884,
    "drug_cycles": 10,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 870
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14788",
    "bcr_drug_uuid": "7e05a613-6102-4584-a478-8610ff8936d5",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2714,
    "drug_cycles": 12,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 134
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14790",
    "bcr_drug_uuid": "83dc3af5-58c5-423c-b1d7-7d9cdaf28df4",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3185,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14789",
    "bcr_drug_uuid": "b3ee688e-79eb-4dd1-a3ee-e73f99ebf877",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2731,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3060,
    "drug_cycles": 26,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 745
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14787",
    "bcr_drug_uuid": "8290859f-c748-4d89-8312-4d66fb7a347b",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2714,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 231
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14791",
    "bcr_drug_uuid": "8f2f4cd2-4301-4be8-bdf3-ae8741ec4bc5",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3185,
    "drug_cycles": 2,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 745
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14799",
    "bcr_drug_uuid": "18e4081d-6f45-4245-899d-7df6394f7000",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3227,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3581,
    "drug_cycles": 14,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 15,
    "regimen_number": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1172
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14784",
    "bcr_drug_uuid": "16a48912-089b-46f1-a756-6ee83dfce1a8",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 506,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 385
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14785",
    "bcr_drug_uuid": "4b18ce80-40f5-4f5e-99c8-9949a8689e9f",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1632,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 370
  },
  {
    "bcr_patient_uuid": "c0d47e0f-4918-4e06-9db6-201671b1259c",
    "patient_ID": "TCGA.DU.6404",
    "bcr_drug_barcode": "TCGA-DU-6404-D14804",
    "bcr_drug_uuid": "4784091c-7545-4001-bb2f-b2d9920e698b",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 4066,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4066,
    "drug_cycles": 1,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 635
  },
  {
    "bcr_patient_uuid": "9239a22e-80b1-49a2-b0d5-cbab7e415254",
    "patient_ID": "TCGA.DU.6405",
    "bcr_drug_barcode": "TCGA-DU-6405-D14688",
    "bcr_drug_uuid": "ef4f3748-8fcf-402a-ac1c-21d617d6ca73",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "PS-341 BORTREZOMIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 530,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1.25,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 203
  },
  {
    "bcr_patient_uuid": "9239a22e-80b1-49a2-b0d5-cbab7e415254",
    "patient_ID": "TCGA.DU.6405",
    "bcr_drug_barcode": "TCGA-DU-6405-D14686",
    "bcr_drug_uuid": "b07896a6-e8ed-435f-9d49-ba2acf9186f9",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "9239a22e-80b1-49a2-b0d5-cbab7e415254",
    "patient_ID": "TCGA.DU.6405",
    "bcr_drug_barcode": "TCGA-DU-6405-D14687",
    "bcr_drug_uuid": "27ec47b6-4503-4cfb-938a-0d32d623545e",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 499,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "9239a22e-80b1-49a2-b0d5-cbab7e415254",
    "patient_ID": "TCGA.DU.6405",
    "bcr_drug_barcode": "TCGA-DU-6405-D14690",
    "bcr_drug_uuid": "d5d78110-5704-4e12-81e1-1d959f123460",
    "form_completion_date": "2011-6-21",
    "pharmaceutical_therapy_drug_name": "CILENGITIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 561,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1086
  },
  {
    "bcr_patient_uuid": "c13a429c-99ea-478c-ae95-fa499b9ea9fa",
    "patient_ID": "TCGA.DU.6406",
    "bcr_drug_barcode": "TCGA-DU-6406-D14903",
    "bcr_drug_uuid": "101eea12-9909-41a3-906e-ee2fcc94ba4f",
    "form_completion_date": "2011-6-1",
    "pharmaceutical_therapy_drug_name": "ISOTRECTINOIN (ACCCUTANE)",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "drug_cycles": 5,
    "pharma_type_other": "RETINOID",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c13a429c-99ea-478c-ae95-fa499b9ea9fa",
    "patient_ID": "TCGA.DU.6406",
    "bcr_drug_barcode": "TCGA-DU-6406-D14901",
    "bcr_drug_uuid": "0bfe64d1-8cc5-44fc-8cda-42dd1458a08f",
    "form_completion_date": "2011-6-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c13a429c-99ea-478c-ae95-fa499b9ea9fa",
    "patient_ID": "TCGA.DU.6406",
    "bcr_drug_barcode": "TCGA-DU-6406-D14902",
    "bcr_drug_uuid": "2edd84a0-4c13-456b-8485-48de001ab22e",
    "form_completion_date": "2011-6-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 280,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "70939245-41e0-4845-a473-5fef719b9828",
    "patient_ID": "TCGA.DU.6407",
    "bcr_drug_barcode": "TCGA-DU-6407-D14953",
    "bcr_drug_uuid": "68261acf-ff6e-43d0-988b-57cd040ec0be",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2473,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2516,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "70939245-41e0-4845-a473-5fef719b9828",
    "patient_ID": "TCGA.DU.6407",
    "bcr_drug_barcode": "TCGA-DU-6407-D14954",
    "bcr_drug_uuid": "b946be0f-487d-4707-9e9c-c8564ed98487",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2531,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2774,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "70939245-41e0-4845-a473-5fef719b9828",
    "patient_ID": "TCGA.DU.6407",
    "bcr_drug_barcode": "TCGA-DU-6407-D14956",
    "bcr_drug_uuid": "d0c4833a-a750-4848-84b9-24bb8743c492",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "AFATINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2836,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2853,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "70939245-41e0-4845-a473-5fef719b9828",
    "patient_ID": "TCGA.DU.6407",
    "bcr_drug_barcode": "TCGA-DU-6407-D14955",
    "bcr_drug_uuid": "51323f8f-090f-40a1-b44e-7cb7117bd90f",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2835,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2853,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "14375753-a69f-41e0-b910-2bb8e84cc43a",
    "patient_ID": "TCGA.DU.6408",
    "bcr_drug_barcode": "TCGA-DU-6408-D14910",
    "bcr_drug_uuid": "37c7aca8-52b5-4421-9922-52ea6ab89b0a",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1226,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "14375753-a69f-41e0-b910-2bb8e84cc43a",
    "patient_ID": "TCGA.DU.6408",
    "bcr_drug_barcode": "TCGA-DU-6408-D14911",
    "bcr_drug_uuid": "8ac55ee4-7db3-4a31-817c-de2a0893a41c",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "14375753-a69f-41e0-b910-2bb8e84cc43a",
    "patient_ID": "TCGA.DU.6408",
    "bcr_drug_barcode": "TCGA-DU-6408-D14913",
    "bcr_drug_uuid": "bf35364e-fbff-4d21-b3fc-dff1ce09cb5d",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "14375753-a69f-41e0-b910-2bb8e84cc43a",
    "patient_ID": "TCGA.DU.6408",
    "bcr_drug_barcode": "TCGA-DU-6408-D14914",
    "bcr_drug_uuid": "4e0b69f2-a12d-42b1-8d9e-118a8d889a24",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "CAPECITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "467a7e6a-8cba-4ef1-8afd-6c8eaccbc3df",
    "patient_ID": "TCGA.DU.6410",
    "bcr_drug_barcode": "TCGA-DU-6410-D15161",
    "bcr_drug_uuid": "86f1b69a-ced9-4edf-9c4e-7b34d0dfbb85",
    "form_completion_date": "2011-6-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "cd69d509-a652-4257-a8d3-767296bbb4ec",
    "patient_ID": "TCGA.DU.6542",
    "bcr_drug_barcode": "TCGA-DU-6542-D18403",
    "bcr_drug_uuid": "bd0dc956-293e-4f72-9177-31732a441d96",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 145
  },
  {
    "bcr_patient_uuid": "cd69d509-a652-4257-a8d3-767296bbb4ec",
    "patient_ID": "TCGA.DU.6542",
    "bcr_drug_barcode": "TCGA-DU-6542-D18405",
    "bcr_drug_uuid": "cf893d09-aefc-4352-abba-97c4bfc43091",
    "form_completion_date": "2011-5-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "215e117c-4d76-463c-8f8a-fd6a28d23929",
    "patient_ID": "TCGA.DU.7006",
    "bcr_drug_barcode": "TCGA-DU-7006-D17929",
    "bcr_drug_uuid": "723ff33b-8869-4952-80a3-3713520d5eae",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "215e117c-4d76-463c-8f8a-fd6a28d23929",
    "patient_ID": "TCGA.DU.7006",
    "bcr_drug_barcode": "TCGA-DU-7006-D17931",
    "bcr_drug_uuid": "316e5e4e-c0f9-4edb-bee5-f09f9f0d5766",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "215e117c-4d76-463c-8f8a-fd6a28d23929",
    "patient_ID": "TCGA.DU.7006",
    "bcr_drug_barcode": "TCGA-DU-7006-D17930",
    "bcr_drug_uuid": "5f4d4b63-37b9-491c-ad99-60cdde292713",
    "form_completion_date": "2011-10-25",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "427c40f6-d1bd-49f2-b303-a975793b937e",
    "patient_ID": "TCGA.DU.7008",
    "bcr_drug_barcode": "TCGA-DU-7008-D17225",
    "bcr_drug_uuid": "ca121445-5755-440b-976f-e7d670875074",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 104,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "427c40f6-d1bd-49f2-b303-a975793b937e",
    "patient_ID": "TCGA.DU.7008",
    "bcr_drug_barcode": "TCGA-DU-7008-D17224",
    "bcr_drug_uuid": "34aab7aa-a5d6-4189-941a-00b031ba04c7",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "LOMUSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "427c40f6-d1bd-49f2-b303-a975793b937e",
    "patient_ID": "TCGA.DU.7008",
    "bcr_drug_barcode": "TCGA-DU-7008-D17223",
    "bcr_drug_uuid": "0e7bb365-16bc-4962-a159-7fa3b7e6b776",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "01c4ca12-ac08-41dd-9e4f-bfb0971688a2",
    "patient_ID": "TCGA.DU.7009",
    "bcr_drug_barcode": "TCGA-DU-7009-D17081",
    "bcr_drug_uuid": "44d75b94-99ef-4bf1-8457-05af11d6ea97",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3095,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3279,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "834e560a-a506-456d-baf2-a206ca058153",
    "patient_ID": "TCGA.DU.7010",
    "bcr_drug_barcode": "TCGA-DU-7010-D17063",
    "bcr_drug_uuid": "caa0c4b5-9983-49d8-95a8-efe28a285e84",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "834e560a-a506-456d-baf2-a206ca058153",
    "patient_ID": "TCGA.DU.7010",
    "bcr_drug_barcode": "TCGA-DU-7010-D17061",
    "bcr_drug_uuid": "fd9d915c-a824-445d-999e-3173cc38d953",
    "form_completion_date": "2011-9-28",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d61b5d20-4d6d-4fdc-afe8-4b100b686eda",
    "patient_ID": "TCGA.DU.7013",
    "bcr_drug_barcode": "TCGA-DU-7013-D17094",
    "bcr_drug_uuid": "909faac9-a567-4223-b445-653d75e77445",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ec82a00f-3909-4781-8ae2-e54cbc1ac7ac",
    "patient_ID": "TCGA.DU.7015",
    "bcr_drug_barcode": "TCGA-DU-7015-D18634",
    "bcr_drug_uuid": "6d0329fe-9b8c-4443-b156-60a52d35590c",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 884,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "ec82a00f-3909-4781-8ae2-e54cbc1ac7ac",
    "patient_ID": "TCGA.DU.7015",
    "bcr_drug_barcode": "TCGA-DU-7015-D18635",
    "bcr_drug_uuid": "8163fd2e-6bd9-4728-89fb-b7b1aaf8868d",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 930,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1460,
    "drug_cycles": 17,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ec82a00f-3909-4781-8ae2-e54cbc1ac7ac",
    "patient_ID": "TCGA.DU.7015",
    "bcr_drug_barcode": "TCGA-DU-7015-D18637",
    "bcr_drug_uuid": "6c6ae3a3-1841-4e11-abd9-db485469e117",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 930,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f18dab99-26b0-4727-89a9-7f16bd382356",
    "patient_ID": "TCGA.DU.7018",
    "bcr_drug_barcode": "TCGA-DU-7018-D17072",
    "bcr_drug_uuid": "0ff38e24-e65f-4420-b997-6be8f0cbe1f4",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 635,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 697,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f18dab99-26b0-4727-89a9-7f16bd382356",
    "patient_ID": "TCGA.DU.7018",
    "bcr_drug_barcode": "TCGA-DU-7018-D17071",
    "bcr_drug_uuid": "de8a8468-26f5-46ad-8a52-b62f67e846ea",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 605,
    "drug_cycles": 17,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 330
  },
  {
    "bcr_patient_uuid": "1b43ff0c-cf13-4620-b5c7-7abd9129612f",
    "patient_ID": "TCGA.DU.7019",
    "bcr_drug_barcode": "TCGA-DU-7019-D17098",
    "bcr_drug_uuid": "768a76e4-31d4-43bc-85d9-e205b2e3b937",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "1b43ff0c-cf13-4620-b5c7-7abd9129612f",
    "patient_ID": "TCGA.DU.7019",
    "bcr_drug_barcode": "TCGA-DU-7019-D17099",
    "bcr_drug_uuid": "407c4659-4e06-40bf-ba0f-7f715113b34f",
    "form_completion_date": "2011-9-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "145f87a3-5e86-4a87-8e49-b166a2271d02",
    "patient_ID": "TCGA.DU.7292",
    "bcr_drug_barcode": "TCGA-DU-7292-D17520",
    "bcr_drug_uuid": "849dca85-f3f7-4138-98cf-26f78f38d3d9",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "TOMAXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 20,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "145f87a3-5e86-4a87-8e49-b166a2271d02",
    "patient_ID": "TCGA.DU.7292",
    "bcr_drug_barcode": "TCGA-DU-7292-D17519",
    "bcr_drug_uuid": "d5d225da-320e-4069-b6ac-2bb4744af8ae",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "292cf158-dd47-44a1-912b-73626095a0f7",
    "patient_ID": "TCGA.DU.7298",
    "bcr_drug_barcode": "TCGA-DU-7298-D17500",
    "bcr_drug_uuid": "0ce65b73-52ed-4e3c-8c63-059390085216",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "292cf158-dd47-44a1-912b-73626095a0f7",
    "patient_ID": "TCGA.DU.7298",
    "bcr_drug_barcode": "TCGA-DU-7298-D17499",
    "bcr_drug_uuid": "cd4abb43-8f0d-4aae-ab32-ff00a06e3023",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "81622da8-9f36-4ea3-b223-d831d8c10f87",
    "patient_ID": "TCGA.DU.7299",
    "bcr_drug_barcode": "TCGA-DU-7299-D18391",
    "bcr_drug_uuid": "70d4e8a3-8e0d-4bed-9501-38f2a5cbef65",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "81622da8-9f36-4ea3-b223-d831d8c10f87",
    "patient_ID": "TCGA.DU.7299",
    "bcr_drug_barcode": "TCGA-DU-7299-D18396",
    "bcr_drug_uuid": "162e312c-756b-489c-a377-99bb5708bd8a",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 945,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "81622da8-9f36-4ea3-b223-d831d8c10f87",
    "patient_ID": "TCGA.DU.7299",
    "bcr_drug_barcode": "TCGA-DU-7299-D18393",
    "bcr_drug_uuid": "a82d62eb-3489-4687-a17a-a46edf04c965",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 945,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 256
  },
  {
    "bcr_patient_uuid": "81622da8-9f36-4ea3-b223-d831d8c10f87",
    "patient_ID": "TCGA.DU.7299",
    "bcr_drug_barcode": "TCGA-DU-7299-D18395",
    "bcr_drug_uuid": "6c6d5e51-9acf-4db8-9c19-b46d4f36c3c5",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1016,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 911
  },
  {
    "bcr_patient_uuid": "81622da8-9f36-4ea3-b223-d831d8c10f87",
    "patient_ID": "TCGA.DU.7299",
    "bcr_drug_barcode": "TCGA-DU-7299-D18392",
    "bcr_drug_uuid": "b7f97f91-d3bd-48ce-a985-648ac665dee8",
    "form_completion_date": "2011-11-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 456,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "a144e4e4-2877-4340-a2bf-524adbde8bc8",
    "patient_ID": "TCGA.DU.7300",
    "bcr_drug_barcode": "TCGA-DU-7300-D17529",
    "bcr_drug_uuid": "c0738f83-af43-470c-b1f3-55d91ecb6c80",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 764,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a144e4e4-2877-4340-a2bf-524adbde8bc8",
    "patient_ID": "TCGA.DU.7300",
    "bcr_drug_barcode": "TCGA-DU-7300-D17530",
    "bcr_drug_uuid": "d2d350cd-bef1-4114-ac7b-7ec3ab44b2f1",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "IRINTOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a144e4e4-2877-4340-a2bf-524adbde8bc8",
    "patient_ID": "TCGA.DU.7300",
    "bcr_drug_barcode": "TCGA-DU-7300-D17531",
    "bcr_drug_uuid": "9fd1c5c0-311e-414e-af6d-45d54346b05f",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1086,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a144e4e4-2877-4340-a2bf-524adbde8bc8",
    "patient_ID": "TCGA.DU.7300",
    "bcr_drug_barcode": "TCGA-DU-7300-D17527",
    "bcr_drug_uuid": "444b1400-212c-4f30-b57b-2d0b8e7b0db3",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "a144e4e4-2877-4340-a2bf-524adbde8bc8",
    "patient_ID": "TCGA.DU.7300",
    "bcr_drug_barcode": "TCGA-DU-7300-D17528",
    "bcr_drug_uuid": "5431dd7a-6389-4069-92a3-6a0d5c8df2d2",
    "form_completion_date": "2011-10-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 337,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 368,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "84ae73e4-3b39-4444-9bfb-3fc6057eab32",
    "patient_ID": "TCGA.DU.7301",
    "bcr_drug_barcode": "TCGA-DU-7301-D17536",
    "bcr_drug_uuid": "0339bf1b-2b0f-4bff-9616-99a7c337c6d4",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "TEMOZLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "84ae73e4-3b39-4444-9bfb-3fc6057eab32",
    "patient_ID": "TCGA.DU.7301",
    "bcr_drug_barcode": "TCGA-DU-7301-D17537",
    "bcr_drug_uuid": "416f8414-2219-49f9-90fb-13a43fb6b5a2",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 534,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "84ae73e4-3b39-4444-9bfb-3fc6057eab32",
    "patient_ID": "TCGA.DU.7301",
    "bcr_drug_barcode": "TCGA-DU-7301-D17538",
    "bcr_drug_uuid": "42dc258d-7ebc-4fb1-8523-b39d28369a1f",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 379,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 629,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1058
  },
  {
    "bcr_patient_uuid": "84ae73e4-3b39-4444-9bfb-3fc6057eab32",
    "patient_ID": "TCGA.DU.7301",
    "bcr_drug_barcode": "TCGA-DU-7301-D17535",
    "bcr_drug_uuid": "da481593-0d3e-4440-bd59-c93ce95df640",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "84ae73e4-3b39-4444-9bfb-3fc6057eab32",
    "patient_ID": "TCGA.DU.7301",
    "bcr_drug_barcode": "TCGA-DU-7301-D17539",
    "bcr_drug_uuid": "ba652ae9-a162-43de-88df-d4fa7bade195",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 626,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 643,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "5a769292-c3ce-4e18-b821-2bfe0e24978c",
    "patient_ID": "TCGA.DU.7302",
    "bcr_drug_barcode": "TCGA-DU-7302-D17546",
    "bcr_drug_uuid": "0cb7bafc-7b49-415e-9c8d-cd09c26933bc",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1691,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "5a769292-c3ce-4e18-b821-2bfe0e24978c",
    "patient_ID": "TCGA.DU.7302",
    "bcr_drug_barcode": "TCGA-DU-7302-D17544",
    "bcr_drug_uuid": "086ba121-af92-44a0-b136-f364d2d61ae8",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 530,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "5a769292-c3ce-4e18-b821-2bfe0e24978c",
    "patient_ID": "TCGA.DU.7302",
    "bcr_drug_barcode": "TCGA-DU-7302-D17545",
    "bcr_drug_uuid": "a3fdb0ab-0826-4b2e-bc73-953b1b75392d",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1686,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 155
  },
  {
    "bcr_patient_uuid": "d61710c1-8ac3-44e3-b567-66288a6ab731",
    "patient_ID": "TCGA.DU.7304",
    "bcr_drug_barcode": "TCGA-DU-7304-D17505",
    "bcr_drug_uuid": "9152384e-f80f-405e-ab67-8634ae067452",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 318,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "d61710c1-8ac3-44e3-b567-66288a6ab731",
    "patient_ID": "TCGA.DU.7304",
    "bcr_drug_barcode": "TCGA-DU-7304-D17506",
    "bcr_drug_uuid": "7670b1e3-d6e8-4f91-9f36-9fa51f2bd638",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 539,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 241
  },
  {
    "bcr_patient_uuid": "d61710c1-8ac3-44e3-b567-66288a6ab731",
    "patient_ID": "TCGA.DU.7304",
    "bcr_drug_barcode": "TCGA-DU-7304-D17507",
    "bcr_drug_uuid": "492b5f3f-0776-4b74-85cf-ffa80d16869d",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 623,
    "drug_cycles": 10,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 759
  },
  {
    "bcr_patient_uuid": "d61710c1-8ac3-44e3-b567-66288a6ab731",
    "patient_ID": "TCGA.DU.7304",
    "bcr_drug_barcode": "TCGA-DU-7304-D17504",
    "bcr_drug_uuid": "87477a13-3bb0-4f08-baab-53f814a9501e",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "c35f36b1-ba3d-4eea-bf5a-c95480202176",
    "patient_ID": "TCGA.DU.7306",
    "bcr_drug_barcode": "TCGA-DU-7306-D17493",
    "bcr_drug_uuid": "d7b62d39-291a-455c-bfa1-f56e105a9589",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "c35f36b1-ba3d-4eea-bf5a-c95480202176",
    "patient_ID": "TCGA.DU.7306",
    "bcr_drug_barcode": "TCGA-DU-7306-D17494",
    "bcr_drug_uuid": "f5e5a76a-cc3a-45ee-b051-c45252fa2d95",
    "form_completion_date": "2011-10-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "c35f36b1-ba3d-4eea-bf5a-c95480202176",
    "patient_ID": "TCGA.DU.7306",
    "bcr_drug_barcode": "TCGA-DU-7306-D17495",
    "bcr_drug_uuid": "c8f0a2bd-3046-41db-bcb7-3774577ca4ae",
    "form_completion_date": "2011-10-12",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1283,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "ca427acb-034e-42e2-961a-b9d5dc30b741",
    "patient_ID": "TCGA.DU.7309",
    "bcr_drug_barcode": "TCGA-DU-7309-D17511",
    "bcr_drug_uuid": "48a26f12-7ec5-410e-827f-8728eae7a1f5",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "b8df1577-2a75-4eb7-ab27-f2dd76160730",
    "patient_ID": "TCGA.DU.8158",
    "bcr_drug_barcode": "TCGA-DU-8158-D33125",
    "bcr_drug_uuid": "6009C075-F6A2-495D-929C-4154C2C079EA",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b9a3b647-61b3-4d98-90ca-e307ab50984a",
    "patient_ID": "TCGA.DU.8161",
    "bcr_drug_barcode": "TCGA-DU-8161-D33115",
    "bcr_drug_uuid": "6F53A1F5-D096-44F4-A3D5-58A2EB152E79",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b9a3b647-61b3-4d98-90ca-e307ab50984a",
    "patient_ID": "TCGA.DU.8161",
    "bcr_drug_barcode": "TCGA-DU-8161-D33116",
    "bcr_drug_uuid": "0576A374-F67E-4078-8448-105A7EC56073",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b9a3b647-61b3-4d98-90ca-e307ab50984a",
    "patient_ID": "TCGA.DU.8161",
    "bcr_drug_barcode": "TCGA-DU-8161-D33117",
    "bcr_drug_uuid": "0FC1D028-5E10-4C7E-B6FC-88DD0BA67079",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 575,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b9a3b647-61b3-4d98-90ca-e307ab50984a",
    "patient_ID": "TCGA.DU.8161",
    "bcr_drug_barcode": "TCGA-DU-8161-D33118",
    "bcr_drug_uuid": "9D020EFF-C8D2-4473-8610-F7D5053A97EE",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6fab9c30-354b-4f99-9b60-6823c12b9b0a",
    "patient_ID": "TCGA.DU.8162",
    "bcr_drug_barcode": "TCGA-DU-8162-D33121",
    "bcr_drug_uuid": "FE9B8EF7-4418-4446-9780-E2ECF8FDB8A4",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "6fab9c30-354b-4f99-9b60-6823c12b9b0a",
    "patient_ID": "TCGA.DU.8162",
    "bcr_drug_barcode": "TCGA-DU-8162-D33122",
    "bcr_drug_uuid": "B2AD4B1D-3B7E-4C0E-A590-A2E7ACB3F597",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 108,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c81d4681-c02f-4b33-abe0-b6ad7d61194d",
    "patient_ID": "TCGA.DU.8163",
    "bcr_drug_barcode": "TCGA-DU-8163-D33105",
    "bcr_drug_uuid": "0C5880BB-0FC8-4729-BBE3-71E46ED49684",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c81d4681-c02f-4b33-abe0-b6ad7d61194d",
    "patient_ID": "TCGA.DU.8163",
    "bcr_drug_barcode": "TCGA-DU-8163-D33106",
    "bcr_drug_uuid": "6EAD861C-E1F5-40A4-AAD1-120B9DA21E15",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c81d4681-c02f-4b33-abe0-b6ad7d61194d",
    "patient_ID": "TCGA.DU.8163",
    "bcr_drug_barcode": "TCGA-DU-8163-D44372",
    "bcr_drug_uuid": "62C7526F-002E-45DA-BD51-8D092A894B92",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f97a9afe-e54a-4ef0-b458-0c77f938552e",
    "patient_ID": "TCGA.DU.8164",
    "bcr_drug_barcode": "TCGA-DU-8164-D33147",
    "bcr_drug_uuid": "D44F7932-9A40-4D47-BBBB-AA99E873F87A",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "11dffe71-b516-41e8-9987-e0ff5d2356d1",
    "patient_ID": "TCGA.DU.8165",
    "bcr_drug_barcode": "TCGA-DU-8165-D33110",
    "bcr_drug_uuid": "145B8B1F-FD1F-4CF3-9540-94D864B5D265",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "11dffe71-b516-41e8-9987-e0ff5d2356d1",
    "patient_ID": "TCGA.DU.8165",
    "bcr_drug_barcode": "TCGA-DU-8165-D33111",
    "bcr_drug_uuid": "4859BCE3-A8C5-4D00-BA7C-C4F62A10220E",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e488f613-f155-4e11-87d4-8c789ea81691",
    "patient_ID": "TCGA.DU.8166",
    "bcr_drug_barcode": "TCGA-DU-8166-D44354",
    "bcr_drug_uuid": "03D4FB11-E295-4227-B12E-3021FB09BC50",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e488f613-f155-4e11-87d4-8c789ea81691",
    "patient_ID": "TCGA.DU.8166",
    "bcr_drug_barcode": "TCGA-DU-8166-D44355",
    "bcr_drug_uuid": "2F9D24F7-6365-4143-90DF-EE052C74E6F0",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e488f613-f155-4e11-87d4-8c789ea81691",
    "patient_ID": "TCGA.DU.8166",
    "bcr_drug_barcode": "TCGA-DU-8166-D44356",
    "bcr_drug_uuid": "A971AAD3-1AD3-494D-8945-35B91A1AF170",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fc8828ae-484d-4fc8-a168-f8bc58ad65b9",
    "patient_ID": "TCGA.DU.8168",
    "bcr_drug_barcode": "TCGA-DU-8168-D33151",
    "bcr_drug_uuid": "A4810C43-5747-4139-B975-76501A8399A3",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fc8828ae-484d-4fc8-a168-f8bc58ad65b9",
    "patient_ID": "TCGA.DU.8168",
    "bcr_drug_barcode": "TCGA-DU-8168-D33152",
    "bcr_drug_uuid": "FC39F971-D16D-40D7-84D1-EF3519EF014F",
    "form_completion_date": "2012-6-21",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "669605F6-39A1-4F8C-81DC-39430FF5F892",
    "patient_ID": "TCGA.DU.A5TP",
    "bcr_drug_barcode": "TCGA-DU-A5TP-D44352",
    "bcr_drug_uuid": "8F23D860-77E3-48FD-B210-A6DD1AF2C924",
    "form_completion_date": "2013-6-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "669605F6-39A1-4F8C-81DC-39430FF5F892",
    "patient_ID": "TCGA.DU.A5TP",
    "bcr_drug_barcode": "TCGA-DU-A5TP-D71613",
    "bcr_drug_uuid": "812D527E-CB77-43FC-A1BB-DD6C70B06C24",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 493,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4BD8EBC1-6F6E-44A2-8544-106901A7BAE5",
    "patient_ID": "TCGA.DU.A5TR",
    "bcr_drug_barcode": "TCGA-DU-A5TR-D44292",
    "bcr_drug_uuid": "62A543A1-22E3-4C0B-817B-2DF6FADDE48B",
    "form_completion_date": "2013-6-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DD163547-43AD-4FE4-873E-83C4C6BE4465",
    "patient_ID": "TCGA.DU.A5TS",
    "bcr_drug_barcode": "TCGA-DU-A5TS-D48194",
    "bcr_drug_uuid": "1CDA5AF0-27B3-4B75-AB14-AF4DECFDF770",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 415,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "699D3BA1-94C8-409F-90C3-E7FE2F1CF825",
    "patient_ID": "TCGA.DU.A5TT",
    "bcr_drug_barcode": "TCGA-DU-A5TT-D44301",
    "bcr_drug_uuid": "5D04902F-3DD4-47DB-9597-CCDBA403750E",
    "form_completion_date": "2013-6-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1C095C4A-DF97-402E-902C-FC83BCF8EF88",
    "patient_ID": "TCGA.DU.A5TU",
    "bcr_drug_barcode": "TCGA-DU-A5TU-D71324",
    "bcr_drug_uuid": "EA6B1A2E-5E6D-4403-8482-A641A0E2C5B2",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D43151",
    "bcr_drug_uuid": "D513EE25-1F99-4AB0-B5E6-1DC3F9A89627",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D43152",
    "bcr_drug_uuid": "AEE678D7-9A1F-42D2-AC2A-2A69B93B504A",
    "form_completion_date": "2013-5-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D71311",
    "bcr_drug_uuid": "ACB8A855-B072-4C9B-8DAC-71E04B4E3D8F",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "MIBEFRADIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 812,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D71314",
    "bcr_drug_uuid": "16FD7E66-71DE-46C1-8137-8438D870707D",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 812,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D71315",
    "bcr_drug_uuid": "A53ACC9C-1221-4CF3-AAAC-458E728EEEF8",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 814,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D71316",
    "bcr_drug_uuid": "20EC2652-DBC9-4B60-91D0-72DF2238C13E",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 814,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0167CF11-74BE-4701-AB9A-4E057D4BB545",
    "patient_ID": "TCGA.DU.A5TY",
    "bcr_drug_barcode": "TCGA-DU-A5TY-D71318",
    "bcr_drug_uuid": "77E2D94A-C04E-4377-A483-E5F22FF9E830",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 872,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 914,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3BAA0015-885C-487A-9076-236F404FEB3E",
    "patient_ID": "TCGA.DU.A6S6",
    "bcr_drug_barcode": "TCGA-DU-A6S6-D50317",
    "bcr_drug_uuid": "87C4496C-1A16-4364-910C-E394CEC958FA",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3BAA0015-885C-487A-9076-236F404FEB3E",
    "patient_ID": "TCGA.DU.A6S6",
    "bcr_drug_barcode": "TCGA-DU-A6S6-D50318",
    "bcr_drug_uuid": "2820AAAD-AA7B-470E-944B-24A751CB3616",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2283,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3BAA0015-885C-487A-9076-236F404FEB3E",
    "patient_ID": "TCGA.DU.A6S6",
    "bcr_drug_barcode": "TCGA-DU-A6S6-D71618",
    "bcr_drug_uuid": "92B51D0D-4FD1-40A7-84ED-BCAB8709BC97",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2492,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A56C2083-33D5-4C98-B85F-3B68A3D80ADD",
    "patient_ID": "TCGA.DU.A6S7",
    "bcr_drug_barcode": "TCGA-DU-A6S7-D50314",
    "bcr_drug_uuid": "94B12D32-E713-4FE1-A354-7969289F8195",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A56C2083-33D5-4C98-B85F-3B68A3D80ADD",
    "patient_ID": "TCGA.DU.A6S7",
    "bcr_drug_barcode": "TCGA-DU-A6S7-D50315",
    "bcr_drug_uuid": "B5521E8F-701E-4DC4-B35D-A0B7C318DDD2",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A56C2083-33D5-4C98-B85F-3B68A3D80ADD",
    "patient_ID": "TCGA.DU.A6S7",
    "bcr_drug_barcode": "TCGA-DU-A6S7-D71616",
    "bcr_drug_uuid": "861014FE-D585-429C-8C4B-933CFB115738",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 464,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9CD3B3C6-2268-4E43-964B-B7A4DAF6FC6F",
    "patient_ID": "TCGA.DU.A6S8",
    "bcr_drug_barcode": "TCGA-DU-A6S8-D50231",
    "bcr_drug_uuid": "05FB684B-BCF9-4C5F-9CF7-486F9A4EEA1A",
    "form_completion_date": "2013-10-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "30BF5895-0671-4FB1-A96D-857847FCF7B0",
    "patient_ID": "TCGA.DU.A76K",
    "bcr_drug_barcode": "TCGA-DU-A76K-D50343",
    "bcr_drug_uuid": "67766C84-4517-44DE-BCA9-0A2EEA468543",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 236,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 269,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "395798C5-3136-4A30-8557-A67A3ABDECAF",
    "patient_ID": "TCGA.DU.A76L",
    "bcr_drug_barcode": "TCGA-DU-A76L-D50323",
    "bcr_drug_uuid": "17E31019-21A1-48CA-8472-48CD1CEAD9B5",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "395798C5-3136-4A30-8557-A67A3ABDECAF",
    "patient_ID": "TCGA.DU.A76L",
    "bcr_drug_barcode": "TCGA-DU-A76L-D50324",
    "bcr_drug_uuid": "D3A914AA-DC46-4157-98C9-D4F975FFD86B",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "395798C5-3136-4A30-8557-A67A3ABDECAF",
    "patient_ID": "TCGA.DU.A76L",
    "bcr_drug_barcode": "TCGA-DU-A76L-D50331",
    "bcr_drug_uuid": "225CBF1C-33B0-428A-9718-F9F4236532BA",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 588,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 617,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "395798C5-3136-4A30-8557-A67A3ABDECAF",
    "patient_ID": "TCGA.DU.A76L",
    "bcr_drug_barcode": "TCGA-DU-A76L-D50332",
    "bcr_drug_uuid": "6ACA75BD-AD14-4501-9992-FF1E76A48199",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "CILENGTIDE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 651,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 732,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B",
    "patient_ID": "TCGA.DU.A76O",
    "bcr_drug_barcode": "TCGA-DU-A76O-D50234",
    "bcr_drug_uuid": "1C804B86-2372-4F40-80DC-03362D801B79",
    "form_completion_date": "2013-10-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B",
    "patient_ID": "TCGA.DU.A76O",
    "bcr_drug_barcode": "TCGA-DU-A76O-D50235",
    "bcr_drug_uuid": "4F9A0EDA-E68B-4E0F-AE64-C0A5AD4F12FD",
    "form_completion_date": "2013-10-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "823F571A-3CFD-465D-95FD-187A398CCF6F",
    "patient_ID": "TCGA.DU.A76R",
    "bcr_drug_barcode": "TCGA-DU-A76R-D50337",
    "bcr_drug_uuid": "2B58828D-44A4-445E-AB04-8F22AF55BEE5",
    "form_completion_date": "2013-10-22",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 394,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D54838",
    "bcr_drug_uuid": "B31AF3E2-7AC3-4677-A9D2-FF5D4D0C368B",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D54839",
    "bcr_drug_uuid": "BB8C1762-3228-4014-88BF-A3056543F75F",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 407,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D54840",
    "bcr_drug_uuid": "76C09742-BA08-49FB-85A5-CBFA20A15108",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3061,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3215,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D71630",
    "bcr_drug_uuid": "D69B0F68-C3EC-47F6-B0DC-522C299B0887",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3865,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3901,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D71631",
    "bcr_drug_uuid": "BE695CC6-4636-4C29-BDB6-A048860C0217",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE (CCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4001,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4194,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04E6E843-7F31-43DA-B111-280CE2BD1949",
    "patient_ID": "TCGA.DU.A7T8",
    "bcr_drug_barcode": "TCGA-DU-A7T8-D71632",
    "bcr_drug_uuid": "60D3734B-23AB-40A3-9D2E-8A85A22BC4A0",
    "form_completion_date": "2015-3-27",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 4001,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4194,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF12BFB7-4147-407F-84E9-586DBB10D583",
    "patient_ID": "TCGA.DU.A7TA",
    "bcr_drug_barcode": "TCGA-DU-A7TA-D54834",
    "bcr_drug_uuid": "DE394888-84AB-408B-9F41-E3BEE9D96E4C",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EF12BFB7-4147-407F-84E9-586DBB10D583",
    "patient_ID": "TCGA.DU.A7TA",
    "bcr_drug_barcode": "TCGA-DU-A7TA-D54835",
    "bcr_drug_uuid": "34144EAA-92D6-45E8-A9A8-A1E143BB9761",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D3D8987D-0A54-45F8-B9C9-17EC89FA864E",
    "patient_ID": "TCGA.DU.A7TB",
    "bcr_drug_barcode": "TCGA-DU-A7TB-D56004",
    "bcr_drug_uuid": "2310184D-B65B-4230-891C-E385DB08D9E4",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D3D8987D-0A54-45F8-B9C9-17EC89FA864E",
    "patient_ID": "TCGA.DU.A7TB",
    "bcr_drug_barcode": "TCGA-DU-A7TB-D56005",
    "bcr_drug_uuid": "ACA8EACC-BD7E-464E-9A01-A4C2BF5C9041",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D3D8987D-0A54-45F8-B9C9-17EC89FA864E",
    "patient_ID": "TCGA.DU.A7TB",
    "bcr_drug_barcode": "TCGA-DU-A7TB-D56006",
    "bcr_drug_uuid": "A8CF72D5-C8C6-4786-9DE9-9CCD9F0E687F",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 518,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E349D8AA-BB82-4CE8-B14C-61216289F25B",
    "patient_ID": "TCGA.DU.A7TD",
    "bcr_drug_barcode": "TCGA-DU-A7TD-D56313",
    "bcr_drug_uuid": "D9622AE8-7E36-415A-A2B5-745803CEF0C4",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E349D8AA-BB82-4CE8-B14C-61216289F25B",
    "patient_ID": "TCGA.DU.A7TD",
    "bcr_drug_barcode": "TCGA-DU-A7TD-D56314",
    "bcr_drug_uuid": "300D4223-5E66-4FF5-9DAF-1B6E6E9A1870",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62EC50E7-636E-46C6-AFED-66BF217B59C1",
    "patient_ID": "TCGA.DU.A7TG",
    "bcr_drug_barcode": "TCGA-DU-A7TG-D56330",
    "bcr_drug_uuid": "861B5CB7-3DED-4E28-AED7-0360F4F277F3",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1",
    "patient_ID": "TCGA.DU.A7TI",
    "bcr_drug_barcode": "TCGA-DU-A7TI-D56400",
    "bcr_drug_uuid": "3DBCD02E-18B5-4232-83A3-CBC38B81A66A",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "SU101",
    "clinical_trial_drug_classification": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 567,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1",
    "patient_ID": "TCGA.DU.A7TI",
    "bcr_drug_barcode": "TCGA-DU-A7TI-D56401",
    "bcr_drug_uuid": "FBC93972-332A-4D0B-B1F9-36513FE8138C",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "ONYX-015",
    "clinical_trial_drug_classification": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 840,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 840,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1",
    "patient_ID": "TCGA.DU.A7TI",
    "bcr_drug_barcode": "TCGA-DU-A7TI-D56402",
    "bcr_drug_uuid": "0B8FDF31-EB56-4FB1-8911-0881FCD1E914",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 932,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1085,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1",
    "patient_ID": "TCGA.DU.A7TI",
    "bcr_drug_barcode": "TCGA-DU-A7TI-D56403",
    "bcr_drug_uuid": "8D714D3D-DD1F-44B6-B734-026BF73E8416",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "CIS-RETINOIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0EFAF8F9-177C-4FFB-B03F-F0316ADF5DC1",
    "patient_ID": "TCGA.DU.A7TI",
    "bcr_drug_barcode": "TCGA-DU-A7TI-D56404",
    "bcr_drug_uuid": "F92A10E6-179B-4166-8B5F-6D6EA935DA87",
    "form_completion_date": "2014-2-5",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE (BCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7583",
    "bcr_drug_uuid": "cbc81bae-7c74-4d4e-909e-78de7bec5416",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1303,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7574",
    "bcr_drug_uuid": "2dcf157b-be37-47b2-bf3c-7b00b52229a6",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7580",
    "bcr_drug_uuid": "61f57525-7536-466e-baa5-6479ad79ba99",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 294,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7575",
    "bcr_drug_uuid": "2d204677-5bb2-41ec-bf6e-f4fa7598a8df",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1.4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7586",
    "bcr_drug_uuid": "ffda16d4-ddf9-4f0a-aa66-7096203b6965",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1434,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1493,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3700
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7577",
    "bcr_drug_uuid": "9a3dd9aa-87ee-4227-af43-6166975ee44b",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7585",
    "bcr_drug_uuid": "675eb0bf-0fe1-4378-8402-07804245657e",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1434,
    "drug_cycles": 3,
    "pharma_type_other": "NSAID",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100800
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7576",
    "bcr_drug_uuid": "45fdba35-ce60-4fd5-a286-d019d4420eca",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7582",
    "bcr_drug_uuid": "d51c21de-9ee1-4f03-9204-7c5eaf5f1647",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1255,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1303,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7579",
    "bcr_drug_uuid": "89e69533-028b-448e-a26c-763557be3b07",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7581",
    "bcr_drug_uuid": "f8ac81dc-e450-4733-8d88-27b575fb5e04",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 643,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11100
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7578",
    "bcr_drug_uuid": "cd15de85-acfa-4ddb-b91d-ce601ea1fec3",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1.4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "837b51d0-e6b7-431b-a5f3-7615bdf12b67",
    "patient_ID": "TCGA.E1.5302",
    "bcr_drug_barcode": "TCGA-E1-5302-D7584",
    "bcr_drug_uuid": "c5b80291-66ea-4e01-815c-852f2e3ca534",
    "form_completion_date": "2011-1-16",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1434,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5670
  },
  {
    "bcr_patient_uuid": "44a5c3b4-62a7-407b-b492-7069e1a43a26",
    "patient_ID": "TCGA.E1.5303",
    "bcr_drug_barcode": "TCGA-E1-5303-D7459",
    "bcr_drug_uuid": "7031c972-5b2d-490d-a80e-b578837a941f",
    "form_completion_date": "2011-1-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 582,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 19375
  },
  {
    "bcr_patient_uuid": "44a5c3b4-62a7-407b-b492-7069e1a43a26",
    "patient_ID": "TCGA.E1.5303",
    "bcr_drug_barcode": "TCGA-E1-5303-D7456",
    "bcr_drug_uuid": "834cdac1-d3ad-4199-a1dd-4bba5c989fd1",
    "form_completion_date": "2011-1-19",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "44a5c3b4-62a7-407b-b492-7069e1a43a26",
    "patient_ID": "TCGA.E1.5303",
    "bcr_drug_barcode": "TCGA-E1-5303-D7457",
    "bcr_drug_uuid": "899ae1b9-557b-4dd0-a562-d761ba723890",
    "form_completion_date": "2011-1-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1120
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7553",
    "bcr_drug_uuid": "b6b37b85-64d1-4954-bc27-52ef5a91f85f",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7556",
    "bcr_drug_uuid": "4266f715-faf8-4d2a-b45d-e1437dfe2d72",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 312,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 398,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7549",
    "bcr_drug_uuid": "be795a9f-dcdf-4a7d-aa4f-94b92b08bd4b",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7554",
    "bcr_drug_uuid": "95c00cf2-46a2-4357-9580-f19c65b86363",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3950
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7560",
    "bcr_drug_uuid": "6d9b29fb-5777-4b46-aaaf-703389881871",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1113,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7700
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7566",
    "bcr_drug_uuid": "6b8d7114-8189-4922-a268-49d24d41d79e",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1198,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 10,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7563",
    "bcr_drug_uuid": "21d4ba99-933d-45ca-b175-dde2cbeb3208",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1166,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 125,
    "regimen_number": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 723
  },
  {
    "bcr_patient_uuid": "691d5202-90cc-4e08-83a3-0620a89d3a4b",
    "patient_ID": "TCGA.E1.5304",
    "bcr_drug_barcode": "TCGA-E1-5304-D7551",
    "bcr_drug_uuid": "a306ab5e-3ea9-444f-b6e0-4bbff0380335",
    "form_completion_date": "2011-1-20",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16186",
    "bcr_drug_uuid": "cc8b2398-6351-496d-bfa5-956192b8589e",
    "form_completion_date": "2011-8-8",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2280,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2331,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "drug_total_dose": 220
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16187",
    "bcr_drug_uuid": "5d578bf2-fe1e-4e7f-8523-d97643d02d5f",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 25200
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16188",
    "bcr_drug_uuid": "9f0d6b1f-f74b-4767-9651-07f383616e6a",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 18600
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16189",
    "bcr_drug_uuid": "3c3689e6-abc3-4764-919c-996ab92275b6",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "HYDROYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1636,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1825,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16190",
    "bcr_drug_uuid": "829f988e-fba1-419d-812d-1e060a1124fd",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1636,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1825,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 500,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16192",
    "bcr_drug_uuid": "5b398d6b-46a5-4af0-bb70-090461da40f1",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1994,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14400
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16191",
    "bcr_drug_uuid": "fc80d459-8d13-46dd-bf95-7a1e5482fcb6",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1994,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16193",
    "bcr_drug_uuid": "b6d30749-dc7c-4990-8996-85babd3a83e0",
    "form_completion_date": "2011-8-9",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1994,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2093,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 340,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5440
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16194",
    "bcr_drug_uuid": "08d7b369-80c0-4476-bd5c-0183cf96984c",
    "form_completion_date": "2011-8-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2241,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 730,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 81760
  },
  {
    "bcr_patient_uuid": "a0bc5147-d9b4-41fd-8df3-a241d23722e8",
    "patient_ID": "TCGA.E1.5305",
    "bcr_drug_barcode": "TCGA-E1-5305-D16195",
    "bcr_drug_uuid": "21b355a2-4ea3-473b-b4ad-f238bd434a78",
    "form_completion_date": "2011-8-11",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2241,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10192
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16200",
    "bcr_drug_uuid": "44bf42b3-c194-4c93-9a88-42447409a82f",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 229,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 260,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16206",
    "bcr_drug_uuid": "f9c645bb-d341-4d79-9d1a-b1bb3018a1d4",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1599,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16202",
    "bcr_drug_uuid": "9a84e651-ef5f-4428-9a41-9abe3f200b09",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 313,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 351,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16205",
    "bcr_drug_uuid": "d7f710d5-d665-4d0c-9092-28c16ca3cd47",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 560,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1453,
    "drug_cycles": 41,
    "pharma_type_other": "ANTIONGIOGENIC",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 45920
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16204",
    "bcr_drug_uuid": "8ae3fefe-fa9b-4330-a82b-b331c3757014",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3750
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16199",
    "bcr_drug_uuid": "f796702a-6646-41d0-8bf5-02c53810a781",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16203",
    "bcr_drug_uuid": "a05e8ef2-3ab3-4592-9849-4c7a8d2225da",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 466,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16207",
    "bcr_drug_uuid": "66c28e64-827c-4f8c-9f50-10830898b436",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1599,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1720,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "a6ee311c-0a7b-4f47-86f1-f2164b128f9c",
    "patient_ID": "TCGA.E1.5307",
    "bcr_drug_barcode": "TCGA-E1-5307-D16201",
    "bcr_drug_uuid": "c8dca0fe-e3b8-4666-9e57-0bf36edf5219",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1675
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7605",
    "bcr_drug_uuid": "30aab203-831a-45a5-a8bb-a12345ebb0fb",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2799,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 13200
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7609",
    "bcr_drug_uuid": "093fbbe5-b3b5-4b77-aae3-1290f4970a0a",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2925,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3282,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7612",
    "bcr_drug_uuid": "09853759-bc18-4985-a43b-250c56485528",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "CLORETAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3868,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3996,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2040
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7606",
    "bcr_drug_uuid": "d0f8800f-d92b-4fef-9e99-4ed9b6730e9b",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "KARERLTECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2825,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2848,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.2,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7613",
    "bcr_drug_uuid": "3b12c8ac-446c-48f9-83c7-b47fd1922807",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3996,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4084,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6930
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7611",
    "bcr_drug_uuid": "23ccb473-f54d-4bbd-a42f-5a08ba5eb8e3",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 3282,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3868,
    "drug_cycles": 19,
    "pharma_type_other": "NSAID",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 425600
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7610",
    "bcr_drug_uuid": "ab0c2859-49f7-44b4-95c2-cd241ada23fc",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 3282,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3749,
    "drug_cycles": 15,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 84000
  },
  {
    "bcr_patient_uuid": "0061e9ef-df6a-414e-af64-c88f8192e2d3",
    "patient_ID": "TCGA.E1.5311",
    "bcr_drug_barcode": "TCGA-E1-5311-D7604",
    "bcr_drug_uuid": "9c1483be-c582-4e5c-8521-bff2d3373ffa",
    "form_completion_date": "2011-1-25",
    "pharmaceutical_therapy_drug_name": "MAGI131-81C6",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 20,
    "drug_cycles": 1,
    "pharma_type_other": "BRACHYTHERPY",
    "drug_units": "MCI",
    "drug_tota_dose_units": "MCI",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7631",
    "bcr_drug_uuid": "4fbbc709-b41c-4ba8-ac98-21ead1ae43cf",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1980,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2043,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7629",
    "bcr_drug_uuid": "0b29e6cd-3baa-44d6-8169-0fdb64b67e0e",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1655,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1904,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7622",
    "bcr_drug_uuid": "74468cb9-fcf4-4b97-a28f-164a5d94f934",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 824,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1026,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7641",
    "bcr_drug_uuid": "f3a68eda-ff46-4f81-a053-350e269044ed",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "TAMOXITEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2267,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 80,
    "regimen_number": 12,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4480
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7620",
    "bcr_drug_uuid": "c339ebe1-aa49-47c8-8088-5428d4e2f3b2",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "TEMAZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 781,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 824,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7628",
    "bcr_drug_uuid": "ed6e5212-874d-425d-8a55-fc01a6fe7210",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1590,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1652,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7638",
    "bcr_drug_uuid": "7969fe3e-4682-4dee-bff6-7132ab8e916c",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2267,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 12,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7619",
    "bcr_drug_uuid": "c5a29f35-97d1-47f2-87fb-afa2b3ce97e5",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 385,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 781,
    "drug_cycles": 11,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 560,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6507
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7633",
    "bcr_drug_uuid": "bf3b38cc-7ed0-4a72-a3ff-78ce8f745487",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1980,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2043,
    "drug_cycles": 2,
    "pharma_type_other": "NSAIDS",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 44800
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7635",
    "bcr_drug_uuid": "40ce51f2-557a-411e-b618-642259b5929d",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2023,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2127,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1710
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7623",
    "bcr_drug_uuid": "d27f585c-53c0-431f-ab79-d54b772620ce",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1043,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1231,
    "drug_cycles": 1,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "regimen_number": 4,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7630",
    "bcr_drug_uuid": "b198aef2-c997-4ab1-b5a8-b44b8baca604",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1904,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1971,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7636",
    "bcr_drug_uuid": "feb703c5-9c8f-4b8f-8353-1131d01355ee",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2211,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 11,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "bcr_patient_uuid": "400b2fa3-baf7-4baa-99b4-88b9f25b5049",
    "patient_ID": "TCGA.E1.5318",
    "bcr_drug_barcode": "TCGA-E1-5318-D7645",
    "bcr_drug_uuid": "ead855f0-e402-4be5-b160-3036d37fb8ed",
    "form_completion_date": "2011-1-26",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2335,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 13,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16174",
    "bcr_drug_uuid": "6d31737d-4921-402e-bc85-10d762ed7932",
    "form_completion_date": "2011-8-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 952,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1385,
    "drug_cycles": 13,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 26650
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16176",
    "bcr_drug_uuid": "b869d193-25b4-4aae-beaa-6f44acda704a",
    "form_completion_date": "2011-8-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1826,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1933,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 560,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 94920
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16175",
    "bcr_drug_uuid": "d27d6d3e-f1bc-4afe-80ec-a894e4d73091",
    "form_completion_date": "2011-8-19",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 1385,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1511,
    "drug_cycles": 4,
    "pharma_type_other": "ANTIONGIGENIC",
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 95200
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16177",
    "bcr_drug_uuid": "04a91ee2-d48f-4bdd-b621-ddab8425a59a",
    "form_completion_date": "2011-8-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1933,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1993,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 450,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50400
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16179",
    "bcr_drug_uuid": "d5514219-5b0e-482f-a2af-027c0ba5427b",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2364,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 6,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16178",
    "bcr_drug_uuid": "90657aae-3bf5-4ed4-9b0b-9588f876b750",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2029,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2121,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16181",
    "bcr_drug_uuid": "da80b4cc-3bf5-4b0b-8f98-d2fb84c55973",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2433,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2587,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 8,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16180",
    "bcr_drug_uuid": "561946e1-a96c-47aa-ae5f-3f1dd8684ea5",
    "form_completion_date": "2011-8-23",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2364,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2433,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 82.5,
    "regimen_number": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "84569c1a-6baa-4380-ae3c-707df1be4618",
    "patient_ID": "TCGA.E1.5319",
    "bcr_drug_barcode": "TCGA-E1-5319-D16182",
    "bcr_drug_uuid": "1e479794-aec8-4230-b7e8-f00f75cf7bf9",
    "form_completion_date": "2011-8-24",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2587,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2818,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 9,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "5ea230a6-77aa-4aa5-867c-09651d481d8b",
    "patient_ID": "TCGA.E1.5322",
    "bcr_drug_barcode": "TCGA-E1-5322-D7467",
    "bcr_drug_uuid": "5f1f8156-edae-4626-873b-b85e38a002d4",
    "form_completion_date": "2011-1-27",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFER",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1085,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1109,
    "drug_cycles": 7,
    "drug_units": "WAFER",
    "drug_tota_dose_units": "WAFER",
    "drug_dose": 8,
    "regimen_number": 1,
    "drug_route": "INTRATUMORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8
  },
  {
    "bcr_patient_uuid": "457EC7F6-8612-4641-AAEF-8A7F2C44C30C",
    "patient_ID": "TCGA.E1.A7YD",
    "bcr_drug_barcode": "TCGA-E1-A7YD-D61159",
    "bcr_drug_uuid": "3901572E-7813-4FBB-8E34-1C99B7646119",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "457EC7F6-8612-4641-AAEF-8A7F2C44C30C",
    "patient_ID": "TCGA.E1.A7YD",
    "bcr_drug_barcode": "TCGA-E1-A7YD-D61160",
    "bcr_drug_uuid": "DDC53550-72CF-4515-9AAB-013E69C0E58E",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 314,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61167",
    "bcr_drug_uuid": "FEC71CDC-DE35-494B-98CD-D6220CBB39BD",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61171",
    "bcr_drug_uuid": "749626B5-D27B-4310-97E3-98021E6D8405",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 468,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61176",
    "bcr_drug_uuid": "B567E6D2-B15B-4B4B-A61F-3D3DF2F38AE4",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "GLIADEL WAFERS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61182",
    "bcr_drug_uuid": "8A4C234D-7FE4-4E07-9CD1-2A9F114D0155",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "days_to_drug_start": 482,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 695,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61183",
    "bcr_drug_uuid": "49132B44-9583-4FFA-B258-1E1AB02D5463",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CELEBREX",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 469,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 703,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61185",
    "bcr_drug_uuid": "FC58BB6D-E623-4730-A2E4-6E20F62D0660",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 704,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 731,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61186",
    "bcr_drug_uuid": "16DD15B7-73A8-4C14-A3DA-44798CC4F85B",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "BENZYLGUANINE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 704,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 731,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61190",
    "bcr_drug_uuid": "D184A86B-A497-489C-B3A2-942FA29B3C16",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "KARENITECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 715,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 787,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F842F756-CE78-4C99-BCF8-3BCE18A4D9EF",
    "patient_ID": "TCGA.E1.A7YE",
    "bcr_drug_barcode": "TCGA-E1-A7YE-D61221",
    "bcr_drug_uuid": "F26BB5B1-A15D-4B38-9446-7F43647D04B8",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 845,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61224",
    "bcr_drug_uuid": "C3FB6DAF-CC6E-4337-A4D9-428A04D885F1",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61225",
    "bcr_drug_uuid": "5ABFE853-898E-4AE7-B004-84BA9C9F538A",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61226",
    "bcr_drug_uuid": "497713B5-E927-49B8-BCDF-987ED2BD152D",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 537,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61228",
    "bcr_drug_uuid": "AED54027-D9B2-47BF-A61C-FE8F7F7A96CD",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 752,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61231",
    "bcr_drug_uuid": "0E15F21A-0740-4CEA-8117-F322CA019484",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 775,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 835,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61234",
    "bcr_drug_uuid": "4C28D915-D694-4549-BDCD-78BB263BA535",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1223,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61235",
    "bcr_drug_uuid": "9D2F071F-A519-4608-8897-8CB965C09A4C",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1223,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61236",
    "bcr_drug_uuid": "7CAE29FD-FD85-47BA-B60F-BBE33F7D49FF",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "days_to_drug_start": 1224,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1328,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F469EDB-6B12-4EAB-BD6F-9C10034D4CB7",
    "patient_ID": "TCGA.E1.A7YH",
    "bcr_drug_barcode": "TCGA-E1-A7YH-D61238",
    "bcr_drug_uuid": "9CEF76EB-E81C-4496-A154-0999F535C7E9",
    "form_completion_date": "2014-8-14",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1345,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1627,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC6FBB3C-870D-40B5-983B-7C88705E020D",
    "patient_ID": "TCGA.E1.A7YJ",
    "bcr_drug_barcode": "TCGA-E1-A7YJ-D61250",
    "bcr_drug_uuid": "B7766092-014A-4022-B955-64E79DCB5CF6",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC6FBB3C-870D-40B5-983B-7C88705E020D",
    "patient_ID": "TCGA.E1.A7YJ",
    "bcr_drug_barcode": "TCGA-E1-A7YJ-D61252",
    "bcr_drug_uuid": "BC5EE672-52C4-4BF2-B34C-19B1F8E3EB2E",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC6FBB3C-870D-40B5-983B-7C88705E020D",
    "patient_ID": "TCGA.E1.A7YJ",
    "bcr_drug_barcode": "TCGA-E1-A7YJ-D61253",
    "bcr_drug_uuid": "54D88AA0-390E-4D3F-ABF4-A143045CF5F6",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 504,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC6FBB3C-870D-40B5-983B-7C88705E020D",
    "patient_ID": "TCGA.E1.A7YJ",
    "bcr_drug_barcode": "TCGA-E1-A7YJ-D61254",
    "bcr_drug_uuid": "E73CAFDA-7537-40C4-96BB-C655A0C45770",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 518,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC6FBB3C-870D-40B5-983B-7C88705E020D",
    "patient_ID": "TCGA.E1.A7YJ",
    "bcr_drug_barcode": "TCGA-E1-A7YJ-D61258",
    "bcr_drug_uuid": "FC1FB192-BAC6-4038-87DE-C3EA5C46495F",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "MR1-1",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 537,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 541,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "BB4A30D5-4EBA-45DB-B05A-BD843044D508",
    "patient_ID": "TCGA.E1.A7YK",
    "bcr_drug_barcode": "TCGA-E1-A7YK-D61284",
    "bcr_drug_uuid": "04EACA74-1CCC-4875-BDC6-D7D6849194E7",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB4A30D5-4EBA-45DB-B05A-BD843044D508",
    "patient_ID": "TCGA.E1.A7YK",
    "bcr_drug_barcode": "TCGA-E1-A7YK-D61286",
    "bcr_drug_uuid": "21B1EFC1-D066-448B-862F-6CE7E60C5790",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61291",
    "bcr_drug_uuid": "4317867D-7C62-469A-95AA-747361F74413",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61294",
    "bcr_drug_uuid": "C0F27550-D2A5-4841-9DB5-5F2E51B66CB1",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 289,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61295",
    "bcr_drug_uuid": "381F4079-84C8-43DF-9231-EB5855F3D737",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 263,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61296",
    "bcr_drug_uuid": "3FCCA485-3EB4-434A-8384-FEB790C031C9",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61298",
    "bcr_drug_uuid": "51D62C27-BDAA-41CB-8E94-6D04F00C02D2",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96D9249E-501C-49E0-9559-01DA978A9CA6",
    "patient_ID": "TCGA.E1.A7YL",
    "bcr_drug_barcode": "TCGA-E1-A7YL-D61299",
    "bcr_drug_uuid": "6D0E7573-4BF2-4CFF-A210-88ADE42D77F3",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61418",
    "bcr_drug_uuid": "D12571FF-CF1C-4376-8885-5B7847CBE49D",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61420",
    "bcr_drug_uuid": "C19BA868-82B4-412A-8743-11B35002A24A",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61421",
    "bcr_drug_uuid": "D5FB8A4A-6DF7-4FF6-8385-7687062849D3",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61422",
    "bcr_drug_uuid": "63EF275B-6B0B-4476-B394-82070A5BCCB8",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61423",
    "bcr_drug_uuid": "B35CE46A-7BDC-4879-A729-1EAE5D2F1392",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61424",
    "bcr_drug_uuid": "53B68102-4413-48E8-9C09-F96B6B18859E",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 497,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61426",
    "bcr_drug_uuid": "CB216B91-BE59-4485-99E3-A36277377673",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4250AC3C-C8B0-46CE-B9C8-7963BC386041",
    "patient_ID": "TCGA.E1.A7YM",
    "bcr_drug_barcode": "TCGA-E1-A7YM-D61427",
    "bcr_drug_uuid": "229207F3-DA7E-413B-A97B-B2FB4D0A291E",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61437",
    "bcr_drug_uuid": "1A1B6155-B8EB-4E11-BA47-F01D0C6670DD",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61438",
    "bcr_drug_uuid": "74ABFEC7-A861-4AD2-B928-6152BE300B73",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61442",
    "bcr_drug_uuid": "C21303E5-B241-4D5B-875A-8A02CA330EDB",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 484,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61444",
    "bcr_drug_uuid": "74A352D0-4BEB-482A-8997-1116C31AD09A",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 484,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61450",
    "bcr_drug_uuid": "8ED4B60C-CE8A-4638-830F-83A98961CAFD",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 491,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 553,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCC17E9A-6FE3-44FF-963C-D2D850A431F1",
    "patient_ID": "TCGA.E1.A7YN",
    "bcr_drug_barcode": "TCGA-E1-A7YN-D61451",
    "bcr_drug_uuid": "6BAB6C63-2436-4CC9-B2C8-01B94C4FEF9F",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 506,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 632,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "992452EE-8D9F-406B-9708-7BCB60062743",
    "patient_ID": "TCGA.E1.A7YO",
    "bcr_drug_barcode": "TCGA-E1-A7YO-D61453",
    "bcr_drug_uuid": "9D9F9B77-FDFB-420E-B458-FD367D8B7231",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "I131-81C6",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 23,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "75DBC8FB-4DB8-4764-824C-ECCF3A223884",
    "patient_ID": "TCGA.E1.A7YQ",
    "bcr_drug_barcode": "TCGA-E1-A7YQ-D61539",
    "bcr_drug_uuid": "90634921-7D21-4FA2-A5F5-727E4AACF439",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 396,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75DBC8FB-4DB8-4764-824C-ECCF3A223884",
    "patient_ID": "TCGA.E1.A7YQ",
    "bcr_drug_barcode": "TCGA-E1-A7YQ-D61540",
    "bcr_drug_uuid": "52EA3236-D091-43D8-B6B4-E9F026FFD823",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 429,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 512,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75DBC8FB-4DB8-4764-824C-ECCF3A223884",
    "patient_ID": "TCGA.E1.A7YQ",
    "bcr_drug_barcode": "TCGA-E1-A7YQ-D61541",
    "bcr_drug_uuid": "7A823A25-5BF8-44D6-95B4-4EE024A299B2",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 532,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 559,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5E2539E0-2088-43DF-AD2A-F854D8BB6D30",
    "patient_ID": "TCGA.E1.A7YS",
    "bcr_drug_barcode": "TCGA-E1-A7YS-D61559",
    "bcr_drug_uuid": "2E2BE95F-A48A-4AA6-A723-E3789B943E9F",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5E2539E0-2088-43DF-AD2A-F854D8BB6D30",
    "patient_ID": "TCGA.E1.A7YS",
    "bcr_drug_barcode": "TCGA-E1-A7YS-D61560",
    "bcr_drug_uuid": "C5132DE8-7AA1-4C48-A553-400452DEB9CB",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FC3948FB-DF27-4149-BBFB-04443DFECC19",
    "patient_ID": "TCGA.E1.A7YU",
    "bcr_drug_barcode": "TCGA-E1-A7YU-D61577",
    "bcr_drug_uuid": "44D3E63F-E995-4857-8B11-4B9AA355DA5F",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "I 131 81C6",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 6,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61580",
    "bcr_drug_uuid": "7AD57CF9-00E2-4559-B7AD-40FBEAA4326E",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61581",
    "bcr_drug_uuid": "0506D544-A5D6-4023-BAD1-370DFC75744D",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61583",
    "bcr_drug_uuid": "4926D47F-2BAD-4C57-B6E8-73C812870A88",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 507,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61585",
    "bcr_drug_uuid": "6D3239C8-3331-4030-847F-FE7FC26AB248",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 674,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61586",
    "bcr_drug_uuid": "53943E9C-9ABE-4A2C-9110-866DAE738672",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 674,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61587",
    "bcr_drug_uuid": "B074897E-18F6-4840-80E1-526B6416343C",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 824,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61589",
    "bcr_drug_uuid": "0E78805C-5BFF-477A-8883-3F6CED061FCC",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 846,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 887,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61590",
    "bcr_drug_uuid": "DE30E03E-61B6-444E-9F9D-1141A44FEBE9",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "GLEEVEC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 832,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 887,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61592",
    "bcr_drug_uuid": "3DB2CB93-6AFA-4E43-9799-B5F624044D7B",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 888,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 948,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "23C335F6-5749-4443-8AE8-61CCCBB137CB",
    "patient_ID": "TCGA.E1.A7YV",
    "bcr_drug_barcode": "TCGA-E1-A7YV-D61593",
    "bcr_drug_uuid": "420D4CD3-B59D-4097-8180-B35DD38C51FA",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 888,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 948,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EEF573E-6A44-4DC7-8AA7-B136863CE910",
    "patient_ID": "TCGA.E1.A7YW",
    "bcr_drug_barcode": "TCGA-E1-A7YW-D61606",
    "bcr_drug_uuid": "C6A6B183-A122-4AC1-B392-64D8EC4ED163",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 711,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 978,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EEF573E-6A44-4DC7-8AA7-B136863CE910",
    "patient_ID": "TCGA.E1.A7YW",
    "bcr_drug_barcode": "TCGA-E1-A7YW-D61608",
    "bcr_drug_uuid": "E95A013A-8E18-4D40-8DC6-F34CA45CFE04",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 999,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5EEF573E-6A44-4DC7-8AA7-B136863CE910",
    "patient_ID": "TCGA.E1.A7YW",
    "bcr_drug_barcode": "TCGA-E1-A7YW-D61609",
    "bcr_drug_uuid": "EF7E27E9-3B2E-43DF-8540-076341AD9835",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 999,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5EEF573E-6A44-4DC7-8AA7-B136863CE910",
    "patient_ID": "TCGA.E1.A7YW",
    "bcr_drug_barcode": "TCGA-E1-A7YW-D61610",
    "bcr_drug_uuid": "20DC6FA9-757C-4537-902C-7A29D6290FCF",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1040,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1095,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5EEF573E-6A44-4DC7-8AA7-B136863CE910",
    "patient_ID": "TCGA.E1.A7YW",
    "bcr_drug_barcode": "TCGA-E1-A7YW-D61612",
    "bcr_drug_uuid": "60C2DD63-0669-444B-8104-3CDBD15271F6",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 418,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 608,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61626",
    "bcr_drug_uuid": "4A36C2BC-E737-4A26-912B-61212551557A",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 982,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1351,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61629",
    "bcr_drug_uuid": "F865A9A1-5405-4ED7-8982-32BE7D405518",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2470,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61631",
    "bcr_drug_uuid": "B46C8F8D-1DE0-4243-90D2-896143B8DB38",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2465,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2590,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61633",
    "bcr_drug_uuid": "9F5DC724-EF96-4637-8F7A-54D2380DEE17",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4152,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61635",
    "bcr_drug_uuid": "9CDFAC52-BFDF-45CC-9806-B36B7A015161",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4207,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "722C172F-46E6-47A1-82E5-3207278DF89B",
    "patient_ID": "TCGA.E1.A7YY",
    "bcr_drug_barcode": "TCGA-E1-A7YY-D61638",
    "bcr_drug_uuid": "918DD13E-DDC7-4DB8-8A7D-E2C12D364BFB",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 4289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4418,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61676",
    "bcr_drug_uuid": "E49A4E1A-2003-4C46-9203-C77957172ECB",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 213,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61679",
    "bcr_drug_uuid": "3BBF97E6-A99D-4729-9DC4-0D5682FAAD0E",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61684",
    "bcr_drug_uuid": "D7ACEF48-175D-4009-89E8-CBB102479177",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 286,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61685",
    "bcr_drug_uuid": "577CE699-A162-4B2B-A02B-2DCD62513704",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61686",
    "bcr_drug_uuid": "5EF5B9BF-0974-44F1-BB04-29581A402B1A",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97FFBE14-9070-4A5A-8760-225A88834B40",
    "patient_ID": "TCGA.E1.A7Z2",
    "bcr_drug_barcode": "TCGA-E1-A7Z2-D61687",
    "bcr_drug_uuid": "93A4F821-08F8-4977-82FE-6034DCC8A9D2",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3",
    "patient_ID": "TCGA.E1.A7Z3",
    "bcr_drug_barcode": "TCGA-E1-A7Z3-D61695",
    "bcr_drug_uuid": "AF4DC37C-985A-4BF2-A364-273564BB866F",
    "form_completion_date": "2014-8-18",
    "pharmaceutical_therapy_drug_name": "I131-81C6",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1709,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1709,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3",
    "patient_ID": "TCGA.E1.A7Z3",
    "bcr_drug_barcode": "TCGA-E1-A7Z3-D61698",
    "bcr_drug_uuid": "DDFEF29C-B6DB-49E6-AC99-A2F93816731A",
    "form_completion_date": "2014-8-18",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3",
    "patient_ID": "TCGA.E1.A7Z3",
    "bcr_drug_barcode": "TCGA-E1-A7Z3-D61699",
    "bcr_drug_uuid": "3A267015-FFC3-4370-860D-AAB135DB3C2B",
    "form_completion_date": "2014-8-18",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3",
    "patient_ID": "TCGA.E1.A7Z3",
    "bcr_drug_barcode": "TCGA-E1-A7Z3-D61700",
    "bcr_drug_uuid": "7C353942-BAB3-43B8-8530-CFCA1CB6318D",
    "form_completion_date": "2014-8-18",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1911,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1921,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "3AC41CC6-5DFB-40A1-BD13-5DC7CA2BB6F3",
    "patient_ID": "TCGA.E1.A7Z3",
    "bcr_drug_barcode": "TCGA-E1-A7Z3-D61702",
    "bcr_drug_uuid": "35FBE083-45A7-43C7-BDC0-0CF019A52F5A",
    "form_completion_date": "2014-8-18",
    "pharmaceutical_therapy_drug_name": "CPT-11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2072,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61742",
    "bcr_drug_uuid": "45034EE3-2514-4F2E-BDAC-DA0F43B0E592",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "GLIADEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 883,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 883,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61744",
    "bcr_drug_uuid": "DAC8BC69-6B96-4C72-8F2A-081329407FC3",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 896,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 952,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61746",
    "bcr_drug_uuid": "C4B86A27-716A-4EB9-9857-868CEBF922A0",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 974,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61748",
    "bcr_drug_uuid": "B907B025-FF2B-4F61-8A78-B413C29B8826",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "THALIDOMIDE",
    "days_to_drug_start": 1101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61749",
    "bcr_drug_uuid": "C99CD020-7894-4F1F-A627-78E331F26389",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61751",
    "bcr_drug_uuid": "799AA848-1E30-4DC7-8CAA-B6F0AF17B2D8",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "KARENITECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61753",
    "bcr_drug_uuid": "9DF62BE0-F268-4DE1-8030-57475AC58C16",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1834,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61754",
    "bcr_drug_uuid": "0282393A-FCBA-4D4A-AC74-B0D9C5C66032",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1266,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1834,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61756",
    "bcr_drug_uuid": "A7B85916-1068-405F-B574-5D1E8807337B",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 3545,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3888,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61758",
    "bcr_drug_uuid": "0161FE00-CD4D-47E4-879C-208B19B2958B",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 4081,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4124,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61759",
    "bcr_drug_uuid": "7964078B-3059-4440-8855-5ADA2090CFE0",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4081,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4137,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61761",
    "bcr_drug_uuid": "98E606FE-D8E2-423E-A0EF-C9F8D553ED9C",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 4138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4336,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "975E17C2-B93C-4D45-8A85-786F365E4A93",
    "patient_ID": "TCGA.E1.A7Z4",
    "bcr_drug_barcode": "TCGA-E1-A7Z4-D61762",
    "bcr_drug_uuid": "5CD187C5-7576-451C-B84D-341B29CC2732",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 4308,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B10F00F-FDE6-423D-BC36-027931359A5A",
    "patient_ID": "TCGA.E1.A7Z6",
    "bcr_drug_barcode": "TCGA-E1-A7Z6-D61768",
    "bcr_drug_uuid": "5E182D11-B082-4B6B-893A-51EA9ABE7041",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 356,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 705,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B10F00F-FDE6-423D-BC36-027931359A5A",
    "patient_ID": "TCGA.E1.A7Z6",
    "bcr_drug_barcode": "TCGA-E1-A7Z6-D61773",
    "bcr_drug_uuid": "E16FBDC2-F705-40B9-AAF1-4597CD3CACF3",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 907,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 964,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8B10F00F-FDE6-423D-BC36-027931359A5A",
    "patient_ID": "TCGA.E1.A7Z6",
    "bcr_drug_barcode": "TCGA-E1-A7Z6-D61774",
    "bcr_drug_uuid": "86902F7A-58BF-43A9-A43C-9FF453EAC8B3",
    "form_completion_date": "2014-8-19",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 901,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 966,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e09f93e1-1649-48fa-9e2e-d13ac6d50b97",
    "patient_ID": "TCGA.FG.5962",
    "bcr_drug_barcode": "TCGA-FG-5962-D14107",
    "bcr_drug_uuid": "310362a0-7d4a-4042-beec-96856efdea8a",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6720
  },
  {
    "bcr_patient_uuid": "e09f93e1-1649-48fa-9e2e-d13ac6d50b97",
    "patient_ID": "TCGA.FG.5962",
    "bcr_drug_barcode": "TCGA-FG-5962-D14111",
    "bcr_drug_uuid": "08349992-366b-42ba-8cb9-e93b7b024923",
    "form_completion_date": "2011-7-21",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 10800
  },
  {
    "bcr_patient_uuid": "68f550ca-3a33-45e4-b1c9-14f99e543263",
    "patient_ID": "TCGA.FG.5963",
    "bcr_drug_barcode": "TCGA-FG-5963-D9984",
    "bcr_drug_uuid": "cfce2c0b-61d3-452b-ba97-2eed34aca74b",
    "form_completion_date": "2011-4-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "68f550ca-3a33-45e4-b1c9-14f99e543263",
    "patient_ID": "TCGA.FG.5963",
    "bcr_drug_barcode": "TCGA-FG-5963-D42999",
    "bcr_drug_uuid": "B2B918A8-6647-4CAA-A5BA-E962B2ED4CD1",
    "form_completion_date": "2013-5-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 517,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 690,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "68f550ca-3a33-45e4-b1c9-14f99e543263",
    "patient_ID": "TCGA.FG.5963",
    "bcr_drug_barcode": "TCGA-FG-5963-D43000",
    "bcr_drug_uuid": "CC00B63C-9810-4ADC-A195-77E5574FD002",
    "form_completion_date": "2013-5-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 727,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "68f550ca-3a33-45e4-b1c9-14f99e543263",
    "patient_ID": "TCGA.FG.5963",
    "bcr_drug_barcode": "TCGA-FG-5963-D43015",
    "bcr_drug_uuid": "7A6CD594-2F09-408B-BD86-DA385019EF0D",
    "form_completion_date": "2013-5-8",
    "pharmaceutical_therapy_drug_name": "BCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 699,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2cfc07f3-a31c-41a2-a9e3-b708d2421a78",
    "patient_ID": "TCGA.FG.5965",
    "bcr_drug_barcode": "TCGA-FG-5965-D14155",
    "bcr_drug_uuid": "dfd47724-148f-4d6f-8e91-8eb96911e943",
    "form_completion_date": "2011-7-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9500
  },
  {
    "bcr_patient_uuid": "dadd7428-9e4d-4652-9469-ab521b88d529",
    "patient_ID": "TCGA.FG.6688",
    "bcr_drug_barcode": "TCGA-FG-6688-D14644",
    "bcr_drug_uuid": "3882f392-f750-4236-adc1-8196e3e64b74",
    "form_completion_date": "2011-8-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5750
  },
  {
    "bcr_patient_uuid": "dadd7428-9e4d-4652-9469-ab521b88d529",
    "patient_ID": "TCGA.FG.6688",
    "bcr_drug_barcode": "TCGA-FG-6688-D32792",
    "bcr_drug_uuid": "112A79D4-BB4F-4DDC-B489-5234CE6720FA",
    "form_completion_date": "2012-6-12",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8d07b1e8-5d1d-4a43-b616-d29dd58ce5fe",
    "patient_ID": "TCGA.FG.6689",
    "bcr_drug_barcode": "TCGA-FG-6689-D32856",
    "bcr_drug_uuid": "7EDCB89C-DE05-43F5-BFB5-03D43EB7FA16",
    "form_completion_date": "2012-6-14",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 424,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e4d9b696-3311-44e7-9191-fde56c080a00",
    "patient_ID": "TCGA.FG.6691",
    "bcr_drug_barcode": "TCGA-FG-6691-D63746",
    "bcr_drug_uuid": "3B2BB044-E4EE-47E4-96F2-8D84AB7943C3",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5f10cd91-1e03-4016-b35a-8629a1a8fcc9",
    "patient_ID": "TCGA.FG.6692",
    "bcr_drug_barcode": "TCGA-FG-6692-D32839",
    "bcr_drug_uuid": "CCA2C4C1-27B5-4165-8E5D-3FCAFA02E0A2",
    "form_completion_date": "2012-6-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "b342e980-8383-4f1b-bf57-4098c37a536c",
    "patient_ID": "TCGA.FG.7636",
    "bcr_drug_barcode": "TCGA-FG-7636-D19850",
    "bcr_drug_uuid": "7b3133a0-75ec-4ece-b722-8deb8f2823d2",
    "form_completion_date": "2011-12-29",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "1f54d21e-752f-496d-8453-4b9b8738cbce",
    "patient_ID": "TCGA.FG.7638",
    "bcr_drug_barcode": "TCGA-FG-7638-D20408",
    "bcr_drug_uuid": "e75a0f71-b3d0-4896-ad35-9d7062cf4fd7",
    "form_completion_date": "2011-1-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 145,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6090
  },
  {
    "bcr_patient_uuid": "1f54d21e-752f-496d-8453-4b9b8738cbce",
    "patient_ID": "TCGA.FG.7638",
    "bcr_drug_barcode": "TCGA-FG-7638-D43362",
    "bcr_drug_uuid": "E71157DA-8780-4039-A459-78C0B78182C3",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 336,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f54d21e-752f-496d-8453-4b9b8738cbce",
    "patient_ID": "TCGA.FG.7638",
    "bcr_drug_barcode": "TCGA-FG-7638-D43365",
    "bcr_drug_uuid": "2C840323-3AB9-4788-9A3C-40B8FA3AAD99",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1159c88c-39d0-4c03-9c66-36af5340a67a",
    "patient_ID": "TCGA.FG.8181",
    "bcr_drug_barcode": "TCGA-FG-8181-D64420",
    "bcr_drug_uuid": "2D62A107-8CCE-489F-92A4-C38E2B1ACA7F",
    "form_completion_date": "2014-9-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fb3884df-3680-4c5b-8092-981007aeba03",
    "patient_ID": "TCGA.FG.8185",
    "bcr_drug_barcode": "TCGA-FG-8185-D32545",
    "bcr_drug_uuid": "CE3F4131-147E-44A0-A306-3F54F2F9BDFE",
    "form_completion_date": "2012-5-31",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "fb3884df-3680-4c5b-8092-981007aeba03",
    "patient_ID": "TCGA.FG.8185",
    "bcr_drug_barcode": "TCGA-FG-8185-D43369",
    "bcr_drug_uuid": "CDCD9C6D-0CD2-4E48-B07E-DBC61F09EE3A",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5469c0e8-0c58-4870-b897-8fa0704599a7",
    "patient_ID": "TCGA.FG.8189",
    "bcr_drug_barcode": "TCGA-FG-8189-D42251",
    "bcr_drug_uuid": "9A6538E8-AB2B-44EF-A0F5-1AA3B71111EF",
    "form_completion_date": "2013-4-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "clinical_trial_drug_classification": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5469c0e8-0c58-4870-b897-8fa0704599a7",
    "patient_ID": "TCGA.FG.8189",
    "bcr_drug_barcode": "TCGA-FG-8189-D42255",
    "bcr_drug_uuid": "6AD8B764-E9BA-499F-9D06-724575C8DBA0",
    "form_completion_date": "2013-4-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "clinical_trial_drug_classification": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7",
    "patient_ID": "TCGA.FG.8191",
    "bcr_drug_barcode": "TCGA-FG-8191-D32716",
    "bcr_drug_uuid": "3AD13E50-1087-452C-ACA6-CF2E3EFFED20",
    "form_completion_date": "2012-6-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "029b33b1-7ea9-4b77-a615-7eb0e3ebd5e7",
    "patient_ID": "TCGA.FG.8191",
    "bcr_drug_barcode": "TCGA-FG-8191-D43400",
    "bcr_drug_uuid": "EE6C5FFC-7ABE-44E6-BBE6-EFC24033B9A9",
    "form_completion_date": "2013-5-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCE168B1-D2A9-4409-8437-AB382F6D7D31",
    "patient_ID": "TCGA.FG.A4MW",
    "bcr_drug_barcode": "TCGA-FG-A4MW-D39710",
    "bcr_drug_uuid": "2B02C0A0-719B-48E1-A7F1-DEB9BC1C4F78",
    "form_completion_date": "2013-1-30",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCE168B1-D2A9-4409-8437-AB382F6D7D31",
    "patient_ID": "TCGA.FG.A4MW",
    "bcr_drug_barcode": "TCGA-FG-A4MW-D39712",
    "bcr_drug_uuid": "5E3E00F7-6C27-42D4-A54F-744510155C02",
    "form_completion_date": "2013-1-30",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCE168B1-D2A9-4409-8437-AB382F6D7D31",
    "patient_ID": "TCGA.FG.A4MW",
    "bcr_drug_barcode": "TCGA-FG-A4MW-D61645",
    "bcr_drug_uuid": "9B07A59C-3AF4-4CE4-AB86-37E3F96535BA",
    "form_completion_date": "2014-7-2",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 379,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AE4F0714-3B74-46C0-9C1B-F028C7CF2E62",
    "patient_ID": "TCGA.FG.A6J3",
    "bcr_drug_barcode": "TCGA-FG-A6J3-D48232",
    "bcr_drug_uuid": "1EB2DA09-3CFC-44F9-B194-06BBE1D6AE9C",
    "form_completion_date": "2013-9-10",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AE4F0714-3B74-46C0-9C1B-F028C7CF2E62",
    "patient_ID": "TCGA.FG.A6J3",
    "bcr_drug_barcode": "TCGA-FG-A6J3-D48501",
    "bcr_drug_uuid": "9889AC41-FA07-43AF-8AE0-D489D0085685",
    "form_completion_date": "2013-9-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C6CEB220-282E-4EEF-8D36-4CE0A625CF7E",
    "patient_ID": "TCGA.FG.A70Y",
    "bcr_drug_barcode": "TCGA-FG-A70Y-D57573",
    "bcr_drug_uuid": "C7CBCD44-0546-4E1D-A33A-79E3D22C8167",
    "form_completion_date": "2014-3-17",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 515,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 554,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98E82E98-341A-4BCA-92C0-23C65C1BF94F",
    "patient_ID": "TCGA.FG.A70Z",
    "bcr_drug_barcode": "TCGA-FG-A70Z-D52303",
    "bcr_drug_uuid": "BCD4BD78-2CB1-4359-A5B8-C7E9C6ADC425",
    "form_completion_date": "2013-12-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5B199E7E-CC23-4065-88AD-FDFE3D0683D6",
    "patient_ID": "TCGA.FG.A710",
    "bcr_drug_barcode": "TCGA-FG-A710-D52090",
    "bcr_drug_uuid": "05A41623-D7F0-4D8E-BE95-99FD6083FAAE",
    "form_completion_date": "2013-11-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52361",
    "bcr_drug_uuid": "7EB7A18F-9270-4C94-BC38-F4AD094E0753",
    "form_completion_date": "2013-12-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 673,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52581",
    "bcr_drug_uuid": "0EF92496-C0FB-4C0D-8737-B98B06D1C2FC",
    "form_completion_date": "2013-12-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 733,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 774,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52595",
    "bcr_drug_uuid": "2F01441C-80E1-40F1-B28A-BDDDBEF4AC52",
    "form_completion_date": "2013-12-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1097,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52597",
    "bcr_drug_uuid": "1285B580-A770-4193-9D6E-721FB74D941B",
    "form_completion_date": "2013-12-4",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1195,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52600",
    "bcr_drug_uuid": "6DE43068-EE49-4097-B2FD-A873B0930DA2",
    "form_completion_date": "2013-12-4",
    "pharmaceutical_therapy_drug_name": "HYDROXYUREA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1223,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1277,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D52602",
    "bcr_drug_uuid": "09E1B306-CDD8-4C0E-9B48-B96E9F1CE4BE",
    "form_completion_date": "2013-12-4",
    "pharmaceutical_therapy_drug_name": "IMATINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1223,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1277,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D65440",
    "bcr_drug_uuid": "431B95E5-8501-4D87-9B24-78277A0E9D09",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN 5 AUC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F5B6B07-45F5-4DA4-932A-DF9665F6C538",
    "patient_ID": "TCGA.FG.A711",
    "bcr_drug_barcode": "TCGA-FG-A711-D65441",
    "bcr_drug_uuid": "1595ABFC-0102-42B3-B1DD-FE7EA5AC5FAE",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1329,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "872A12B4-8CBD-49D2-AC98-D846587F5794",
    "patient_ID": "TCGA.FG.A87N",
    "bcr_drug_barcode": "TCGA-FG-A87N-D56687",
    "bcr_drug_uuid": "609B9DC5-249A-4272-B573-15F9B08F416E",
    "form_completion_date": "2014-2-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E17E6FD-ED83-471F-91E3-5934885C8E87",
    "patient_ID": "TCGA.FG.A87Q",
    "bcr_drug_barcode": "TCGA-FG-A87Q-D57695",
    "bcr_drug_uuid": "57FB4361-A36C-441E-A313-DC2265AD2F82",
    "form_completion_date": "2014-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5b9d7565-a933-449d-8ffa-ec5f82db2e77",
    "patient_ID": "TCGA.FN.7833",
    "bcr_drug_barcode": "TCGA-FN-7833-D66002",
    "bcr_drug_uuid": "7C0713E1-5F69-498C-BE16-D29E53FCFF1D",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e6c55ba6-4c8a-4ea4-8dde-74d01915db02",
    "patient_ID": "TCGA.HT.7468",
    "bcr_drug_barcode": "TCGA-HT-7468-D21234",
    "bcr_drug_uuid": "639fb2be-a64c-4ee6-baa4-d2381bfbf493",
    "form_completion_date": "2012-2-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e",
    "patient_ID": "TCGA.HT.7469",
    "bcr_drug_barcode": "TCGA-HT-7469-D28784",
    "bcr_drug_uuid": "96B1E5CA-DD30-4FE4-B287-100C3F6650C7",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "b9e2f4d1-866c-4c62-a9c8-8de7eb364a6e",
    "patient_ID": "TCGA.HT.7469",
    "bcr_drug_barcode": "TCGA-HT-7469-D28785",
    "bcr_drug_uuid": "9FC120A9-D05E-4824-9EA4-6EA5F6DBCA2D",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 3,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "fee2114e-f723-4374-91f8-f1dcc6b3eaee",
    "patient_ID": "TCGA.HT.7470",
    "bcr_drug_barcode": "TCGA-HT-7470-D29528",
    "bcr_drug_uuid": "9d3d68dd-e843-4ebf-9e64-8f8aa2349ac7",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "41456932-436e-4cdb-bfe8-97d089656786",
    "patient_ID": "TCGA.HT.7475",
    "bcr_drug_barcode": "TCGA-HT-7475-D28957",
    "bcr_drug_uuid": "e1c1f02b-819c-432b-93a5-4ec7446c64b1",
    "form_completion_date": "2012-3-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 393,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 441,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7840
  },
  {
    "bcr_patient_uuid": "41456932-436e-4cdb-bfe8-97d089656786",
    "patient_ID": "TCGA.HT.7475",
    "bcr_drug_barcode": "TCGA-HT-7475-D29490",
    "bcr_drug_uuid": "ed530a3e-5be2-4690-9291-de69ba2053d6",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2800
  },
  {
    "bcr_patient_uuid": "41456932-436e-4cdb-bfe8-97d089656786",
    "patient_ID": "TCGA.HT.7475",
    "bcr_drug_barcode": "TCGA-HT-7475-D29491",
    "bcr_drug_uuid": "6b138f48-1cb5-40ea-a1ea-fc90b93424ab",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 186,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 360,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "27d0d3cb-16c0-4ba8-9662-95917f665004",
    "patient_ID": "TCGA.HT.7476",
    "bcr_drug_barcode": "TCGA-HT-7476-D21243",
    "bcr_drug_uuid": "1087cef3-36cb-4992-ad47-390efd05380e",
    "form_completion_date": "2012-2-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "27d0d3cb-16c0-4ba8-9662-95917f665004",
    "patient_ID": "TCGA.HT.7476",
    "bcr_drug_barcode": "TCGA-HT-7476-D21244",
    "bcr_drug_uuid": "7b368f14-efc6-449e-a680-2b1dacafae06",
    "form_completion_date": "2012-2-7",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "38f4b9f3-6709-40ff-9a81-5fa2111b1ce6",
    "patient_ID": "TCGA.HT.7477",
    "bcr_drug_barcode": "TCGA-HT-7477-D49436",
    "bcr_drug_uuid": "4844019E-25CF-4290-9A62-5187446664FF",
    "form_completion_date": "2015-3-3",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 428,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a96fabfa-e830-476a-b2a1-899689570bd9",
    "patient_ID": "TCGA.HT.7479",
    "bcr_drug_barcode": "TCGA-HT-7479-D29545",
    "bcr_drug_uuid": "44160ede-5946-4524-88e3-cd6315f0f750",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 480,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9600
  },
  {
    "bcr_patient_uuid": "a96fabfa-e830-476a-b2a1-899689570bd9",
    "patient_ID": "TCGA.HT.7479",
    "bcr_drug_barcode": "TCGA-HT-7479-D29544",
    "bcr_drug_uuid": "36fef324-f74a-471a-9682-0843dc229a3f",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7350
  },
  {
    "bcr_patient_uuid": "325138ab-2947-4131-b40e-971f024723cc",
    "patient_ID": "TCGA.HT.7480",
    "bcr_drug_barcode": "TCGA-HT-7480-D28791",
    "bcr_drug_uuid": "8567ce65-3a07-414f-9c6a-576ab9f63920",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 310,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 18600
  },
  {
    "bcr_patient_uuid": "325138ab-2947-4131-b40e-971f024723cc",
    "patient_ID": "TCGA.HT.7480",
    "bcr_drug_barcode": "TCGA-HT-7480-D28792",
    "bcr_drug_uuid": "e27b6c8a-0651-4081-a876-55751c96ad05",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2189,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 970,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3880
  },
  {
    "bcr_patient_uuid": "325138ab-2947-4131-b40e-971f024723cc",
    "patient_ID": "TCGA.HT.7480",
    "bcr_drug_barcode": "TCGA-HT-7480-D28790",
    "bcr_drug_uuid": "fa3e56bc-52f7-485f-80a5-4d516410bc5e",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 155,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7750
  },
  {
    "bcr_patient_uuid": "448d3e3b-622c-4e79-bb1d-b5f2e92970e8",
    "patient_ID": "TCGA.HT.7482",
    "bcr_drug_barcode": "TCGA-HT-7482-D29533",
    "bcr_drug_uuid": "5e15e3a1-af84-4651-a196-a1b6efb3969a",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "drug_cycles": 10,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 370,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 18500
  },
  {
    "bcr_patient_uuid": "183dd089-e932-4be2-b252-0e8572e7da4e",
    "patient_ID": "TCGA.HT.7483",
    "bcr_drug_barcode": "TCGA-HT-7483-D70767",
    "bcr_drug_uuid": "672863E8-5DFB-4EF4-BA29-D2AD413781A2",
    "form_completion_date": "2015-4-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3287,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7fdf164-a85d-4ff5-9676-d2215ca35403",
    "patient_ID": "TCGA.HT.7601",
    "bcr_drug_barcode": "TCGA-HT-7601-D29581",
    "bcr_drug_uuid": "8cda6fe4-25e5-442c-b5d7-33f807558541",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 310,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3100
  },
  {
    "bcr_patient_uuid": "e7fdf164-a85d-4ff5-9676-d2215ca35403",
    "patient_ID": "TCGA.HT.7601",
    "bcr_drug_barcode": "TCGA-HT-7601-D29580",
    "bcr_drug_uuid": "08d78506-f3de-416d-b43a-155a4da249a0",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 240,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "e7fdf164-a85d-4ff5-9676-d2215ca35403",
    "patient_ID": "TCGA.HT.7601",
    "bcr_drug_barcode": "TCGA-HT-7601-D29579",
    "bcr_drug_uuid": "e48a697d-7554-4e13-8a74-7217a9307ea2",
    "form_completion_date": "2012-3-9",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 36,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5040
  },
  {
    "bcr_patient_uuid": "019c5de9-74fd-48b7-95a3-227532e16c5a",
    "patient_ID": "TCGA.HT.7604",
    "bcr_drug_barcode": "TCGA-HT-7604-D48645",
    "bcr_drug_uuid": "D1A61351-ABC0-43CF-9D78-2C86D8B5E85B",
    "form_completion_date": "2013-9-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2509,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ffcec8e5-9fd3-4b42-a7cb-74761f713cf4",
    "patient_ID": "TCGA.HT.7606",
    "bcr_drug_barcode": "TCGA-HT-7606-D29686",
    "bcr_drug_uuid": "a6fc3d48-fb07-4f09-af63-e2bf104238af",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5720
  },
  {
    "bcr_patient_uuid": "ffcec8e5-9fd3-4b42-a7cb-74761f713cf4",
    "patient_ID": "TCGA.HT.7606",
    "bcr_drug_barcode": "TCGA-HT-7606-D29691",
    "bcr_drug_uuid": "9df05834-b1d3-412b-9b69-0a61dc70e7dc",
    "form_completion_date": "2012-3-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 163,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 470,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 330,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 19800
  },
  {
    "bcr_patient_uuid": "ffcec8e5-9fd3-4b42-a7cb-74761f713cf4",
    "patient_ID": "TCGA.HT.7606",
    "bcr_drug_barcode": "TCGA-HT-7606-D29688",
    "bcr_drug_uuid": "2936878a-df7a-4dee-8fc2-5e319bfdd03d",
    "form_completion_date": "2012-3-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 102,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1300
  },
  {
    "bcr_patient_uuid": "bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee",
    "patient_ID": "TCGA.HT.7609",
    "bcr_drug_barcode": "TCGA-HT-7609-D28836",
    "bcr_drug_uuid": "3eecb529-e763-469f-967e-ccf4df7f927e",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 484,
    "drug_cycles": 12,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 280,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16800
  },
  {
    "bcr_patient_uuid": "bfbc0d1e-2a0b-4c60-8a37-91e3ce4b79ee",
    "patient_ID": "TCGA.HT.7609",
    "bcr_drug_barcode": "TCGA-HT-7609-D28832",
    "bcr_drug_uuid": "5f8b5235-08c0-4073-b842-31c4320b6809",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6860
  },
  {
    "bcr_patient_uuid": "0d61bdbd-24b1-4885-a099-9e42ca7eedcd",
    "patient_ID": "TCGA.HT.7620",
    "bcr_drug_barcode": "TCGA-HT-7620-D29128",
    "bcr_drug_uuid": "610c74ab-459c-4a79-a763-41468eb2c258",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0d61bdbd-24b1-4885-a099-9e42ca7eedcd",
    "patient_ID": "TCGA.HT.7620",
    "bcr_drug_barcode": "TCGA-HT-7620-D29473",
    "bcr_drug_uuid": "4db359b9-40ba-487f-9e64-03906a939784",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "regimen_number": 3,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0d61bdbd-24b1-4885-a099-9e42ca7eedcd",
    "patient_ID": "TCGA.HT.7620",
    "bcr_drug_barcode": "TCGA-HT-7620-D29472",
    "bcr_drug_uuid": "3b4d9fc5-cb4c-4599-8b89-1b6e329774b9",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "0d61bdbd-24b1-4885-a099-9e42ca7eedcd",
    "patient_ID": "TCGA.HT.7620",
    "bcr_drug_barcode": "TCGA-HT-7620-D29553",
    "bcr_drug_uuid": "76638084-d5cc-494f-b4a2-ff3ab6966527",
    "form_completion_date": "2012-3-22",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 285,
    "regimen_number": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "00b18ad6-ff70-41fe-8f4d-0763ac8f28b9",
    "patient_ID": "TCGA.HT.7677",
    "bcr_drug_barcode": "TCGA-HT-7677-D28948",
    "bcr_drug_uuid": "1c6de7b4-f6d8-4a65-85db-4b8a8668e65a",
    "form_completion_date": "2012-3-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9000
  },
  {
    "bcr_patient_uuid": "00b18ad6-ff70-41fe-8f4d-0763ac8f28b9",
    "patient_ID": "TCGA.HT.7677",
    "bcr_drug_barcode": "TCGA-HT-7677-D28947",
    "bcr_drug_uuid": "07093cd9-38cc-401b-8d81-d005b4cfa6b3",
    "form_completion_date": "2012-3-2",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6020
  },
  {
    "bcr_patient_uuid": "3d58ded1-b7cf-420c-ba59-5b424683f0df",
    "patient_ID": "TCGA.HT.7686",
    "bcr_drug_barcode": "TCGA-HT-7686-D29418",
    "bcr_drug_uuid": "66ee4c20-c346-4423-a222-2a1d1f49b1d3",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 145,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 4,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "3d58ded1-b7cf-420c-ba59-5b424683f0df",
    "patient_ID": "TCGA.HT.7686",
    "bcr_drug_barcode": "TCGA-HT-7686-D29417",
    "bcr_drug_uuid": "866496de-3a98-4e61-95e6-7523222fd8d1",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 130,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6110
  },
  {
    "bcr_patient_uuid": "7740824e-905f-47a0-b235-54561ef58ba3",
    "patient_ID": "TCGA.HT.7688",
    "bcr_drug_barcode": "TCGA-HT-7688-D29501",
    "bcr_drug_uuid": "01e3c417-2bac-43f6-8ece-15f0183282c2",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 475,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 22000
  },
  {
    "bcr_patient_uuid": "7740824e-905f-47a0-b235-54561ef58ba3",
    "patient_ID": "TCGA.HT.7688",
    "bcr_drug_barcode": "TCGA-HT-7688-D29500",
    "bcr_drug_uuid": "3f4b71ea-7a01-44c5-a14a-99fdccb4484e",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "7740824e-905f-47a0-b235-54561ef58ba3",
    "patient_ID": "TCGA.HT.7688",
    "bcr_drug_barcode": "TCGA-HT-7688-D29499",
    "bcr_drug_uuid": "45a8a109-14b4-4843-b1e3-645e23dd4a11",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6300
  },
  {
    "bcr_patient_uuid": "d58b535a-6c95-43bb-ad88-0600e6447537",
    "patient_ID": "TCGA.HT.7689",
    "bcr_drug_barcode": "TCGA-HT-7689-D29658",
    "bcr_drug_uuid": "fd8e3b77-837a-4fdb-a3eb-02ef6930f2f8",
    "form_completion_date": "2012-3-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "d58b535a-6c95-43bb-ad88-0600e6447537",
    "patient_ID": "TCGA.HT.7689",
    "bcr_drug_barcode": "TCGA-HT-7689-D29661",
    "bcr_drug_uuid": "8ea0838b-141f-4bbe-87c7-1d89688e3ce7",
    "form_completion_date": "2012-3-15",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6500
  },
  {
    "bcr_patient_uuid": "491ea65b-86c8-4686-99cf-f09505e20183",
    "patient_ID": "TCGA.HT.7693",
    "bcr_drug_barcode": "TCGA-HT-7693-D29612",
    "bcr_drug_uuid": "41536fee-095b-4da9-afaf-2643af23e7bc",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5880
  },
  {
    "bcr_patient_uuid": "491ea65b-86c8-4686-99cf-f09505e20183",
    "patient_ID": "TCGA.HT.7693",
    "bcr_drug_barcode": "TCGA-HT-7693-D29613",
    "bcr_drug_uuid": "a6443c66-e7a4-4edb-87ab-02d7667a8452",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 440,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 370,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20350
  },
  {
    "bcr_patient_uuid": "5017c115-39b8-4c5c-8be6-2cb298d7c641",
    "patient_ID": "TCGA.HT.7695",
    "bcr_drug_barcode": "TCGA-HT-7695-D29606",
    "bcr_drug_uuid": "fae54b60-4659-442e-b848-217b8e971356",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4950
  },
  {
    "bcr_patient_uuid": "40343ebd-0d62-401e-83a4-6cdb57662ec0",
    "patient_ID": "TCGA.HT.7855",
    "bcr_drug_barcode": "TCGA-HT-7855-D29494",
    "bcr_drug_uuid": "5c82c2f1-819d-4077-ba03-c4f7981fbb6c",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 131,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "40343ebd-0d62-401e-83a4-6cdb57662ec0",
    "patient_ID": "TCGA.HT.7855",
    "bcr_drug_barcode": "TCGA-HT-7855-D29493",
    "bcr_drug_uuid": "b4b955cc-a927-42b7-8a44-67a49a078456",
    "form_completion_date": "2012-3-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6880
  },
  {
    "bcr_patient_uuid": "c2c16878-b615-496c-8fcb-d49c97e15551",
    "patient_ID": "TCGA.HT.7856",
    "bcr_drug_barcode": "TCGA-HT-7856-D29425",
    "bcr_drug_uuid": "3d00d873-e11b-4a5a-bd53-06a8739ef4f0",
    "form_completion_date": "2012-3-16",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6240
  },
  {
    "bcr_patient_uuid": "775c04e6-a02d-44a4-86f7-496056edd249",
    "patient_ID": "TCGA.HT.7874",
    "bcr_drug_barcode": "TCGA-HT-7874-D28709",
    "bcr_drug_uuid": "162b36dc-0c84-4e5c-a93b-2f28f7bb9682",
    "form_completion_date": "2012-2-28",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "775c04e6-a02d-44a4-86f7-496056edd249",
    "patient_ID": "TCGA.HT.7874",
    "bcr_drug_barcode": "TCGA-HT-7874-D28817",
    "bcr_drug_uuid": "47e68bc1-347b-402b-9c84-d26927dd3b66",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 240,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "775c04e6-a02d-44a4-86f7-496056edd249",
    "patient_ID": "TCGA.HT.7874",
    "bcr_drug_barcode": "TCGA-HT-7874-D28820",
    "bcr_drug_uuid": "547b1cf3-8792-494e-b3cf-f5cc70be2a51",
    "form_completion_date": "2012-3-1",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 171,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 549,
    "drug_cycles": 11,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 315,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17325
  },
  {
    "bcr_patient_uuid": "c916b9a4-008e-4d79-a50c-f15c3549fcf6",
    "patient_ID": "TCGA.HT.7879",
    "bcr_drug_barcode": "TCGA-HT-7879-D29675",
    "bcr_drug_uuid": "3a2e7d41-80ef-4a00-91c0-ed73bca1c3ff",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "c916b9a4-008e-4d79-a50c-f15c3549fcf6",
    "patient_ID": "TCGA.HT.7879",
    "bcr_drug_barcode": "TCGA-HT-7879-D29676",
    "bcr_drug_uuid": "c67036e4-e84e-453f-88e4-393a46c1ab59",
    "form_completion_date": "2012-3-19",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG/DAY",
    "drug_dose": 250,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "86aa5790-9afd-4653-926a-625516df1f56",
    "patient_ID": "TCGA.HT.7884",
    "bcr_drug_barcode": "TCGA-HT-7884-D35007",
    "bcr_drug_uuid": "B10095BE-6E20-46D6-92AD-0C978F3ED062",
    "form_completion_date": "2012-9-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "86aa5790-9afd-4653-926a-625516df1f56",
    "patient_ID": "TCGA.HT.7884",
    "bcr_drug_barcode": "TCGA-HT-7884-D35008",
    "bcr_drug_uuid": "9460EED9-0696-49E1-846F-0C0B13665B01",
    "form_completion_date": "2012-9-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "58de25d5-8a32-4412-866b-acac2e321bfa",
    "patient_ID": "TCGA.HT.8011",
    "bcr_drug_barcode": "TCGA-HT-8011-D33342",
    "bcr_drug_uuid": "3218f23a-a617-4724-80a9-5973642659fa",
    "form_completion_date": "2012-6-28",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58de25d5-8a32-4412-866b-acac2e321bfa",
    "patient_ID": "TCGA.HT.8011",
    "bcr_drug_barcode": "TCGA-HT-8011-D33343",
    "bcr_drug_uuid": "53ff0b18-267b-4a80-bfa6-ec2a9fea7d27",
    "form_completion_date": "2012-6-28",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e669a4b7-a494-490a-b78c-e664c59d0697",
    "patient_ID": "TCGA.HT.8013",
    "bcr_drug_barcode": "TCGA-HT-8013-D32630",
    "bcr_drug_uuid": "b4d2d8dd-f207-479c-b56d-c7881078d4e5",
    "form_completion_date": "2012-6-4",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1742,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e669a4b7-a494-490a-b78c-e664c59d0697",
    "patient_ID": "TCGA.HT.8013",
    "bcr_drug_barcode": "TCGA-HT-8013-D32631",
    "bcr_drug_uuid": "4645a0aa-b790-479c-8477-eee9994bbcd1",
    "form_completion_date": "2012-6-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1610,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1693,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9e621541-d603-4d2d-b86e-2834d3b9f9a5",
    "patient_ID": "TCGA.HT.8113",
    "bcr_drug_barcode": "TCGA-HT-8113-D32201",
    "bcr_drug_uuid": "af5f47b4-f241-4cbe-8a7b-920f8954e465",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "treatment_best_response": "PARTIAL RESPONSE"
  },
  {
    "bcr_patient_uuid": "9e621541-d603-4d2d-b86e-2834d3b9f9a5",
    "patient_ID": "TCGA.HT.8113",
    "bcr_drug_barcode": "TCGA-HT-8113-D32203",
    "bcr_drug_uuid": "9b6c6140-feb6-420d-914a-2878bb3a53cd",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "0906ddde-02fa-417d-927b-1c400b189cac",
    "patient_ID": "TCGA.HT.8114",
    "bcr_drug_barcode": "TCGA-HT-8114-D32195",
    "bcr_drug_uuid": "de018a73-b77a-4b82-8378-096ec5e811c3",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "f625e522-226b-450f-af94-dd2f5adb605e",
    "patient_ID": "TCGA.HT.8564",
    "bcr_drug_barcode": "TCGA-HT-8564-D46310",
    "bcr_drug_uuid": "A467D99D-A6A9-47BA-9227-A7A5A32D15EF",
    "form_completion_date": "2013-8-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f625e522-226b-450f-af94-dd2f5adb605e",
    "patient_ID": "TCGA.HT.8564",
    "bcr_drug_barcode": "TCGA-HT-8564-D48471",
    "bcr_drug_uuid": "D4B869E8-9EF1-4643-A4AA-808180CF2CC5",
    "form_completion_date": "2013-9-13",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 184,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f625e522-226b-450f-af94-dd2f5adb605e",
    "patient_ID": "TCGA.HT.8564",
    "bcr_drug_barcode": "TCGA-HT-8564-D48472",
    "bcr_drug_uuid": "931B1FAA-BED3-4C58-99D3-EE734B75C3C3",
    "form_completion_date": "2013-9-13",
    "pharmaceutical_therapy_drug_name": "CEENU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "274496D6-0A9B-45CA-876F-B91F7277963C",
    "patient_ID": "TCGA.HT.A4DV",
    "bcr_drug_barcode": "TCGA-HT-A4DV-D48378",
    "bcr_drug_uuid": "2C642F10-B652-4553-8D9C-53D492BB6A6B",
    "form_completion_date": "2013-9-12",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "274496D6-0A9B-45CA-876F-B91F7277963C",
    "patient_ID": "TCGA.HT.A4DV",
    "bcr_drug_barcode": "TCGA-HT-A4DV-D61276",
    "bcr_drug_uuid": "D99F0E38-B007-4A0A-925D-2A5F6BDEFA73",
    "form_completion_date": "2014-6-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 291,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7E41BABA-7EF6-4030-B595-D95CD96336B5",
    "patient_ID": "TCGA.HT.A5R7",
    "bcr_drug_barcode": "TCGA-HT-A5R7-D51388",
    "bcr_drug_uuid": "7FAB670A-73A4-4F32-9271-75849742F9B3",
    "form_completion_date": "2013-11-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5A2D3BFA-4BDD-417D-9796-E3699760114C",
    "patient_ID": "TCGA.HT.A5RA",
    "bcr_drug_barcode": "TCGA-HT-A5RA-D46308",
    "bcr_drug_uuid": "2A957B8F-61B9-4634-A9CE-D22F4F67B074",
    "form_completion_date": "2013-8-5",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8655FA51-D784-4F8D-9BC8-F1DA7303D22F",
    "patient_ID": "TCGA.HT.A5RC",
    "bcr_drug_barcode": "TCGA-HT-A5RC-D55966",
    "bcr_drug_uuid": "7A0FFB90-CF53-43F0-828E-76B39D3E3FF2",
    "form_completion_date": "2014-1-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A4E2E507-7DDF-43DF-B959-FE451971AF1E",
    "patient_ID": "TCGA.HT.A618",
    "bcr_drug_barcode": "TCGA-HT-A618-D48309",
    "bcr_drug_uuid": "AB2785F9-9744-4CE6-A919-C7229D9F7AD6",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C13BAC88-C85B-4EE3-A51C-FD503CD7E726",
    "patient_ID": "TCGA.HT.A619",
    "bcr_drug_barcode": "TCGA-HT-A619-D58741",
    "bcr_drug_uuid": "4547018B-20B4-4A95-979B-A37634FD7041",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EFFB5839-24A2-4B8C-8B6D-08CB66503D16",
    "patient_ID": "TCGA.HT.A61A",
    "bcr_drug_barcode": "TCGA-HT-A61A-D55964",
    "bcr_drug_uuid": "D5FD6C40-BDE5-4B92-85B8-26D505579FC4",
    "form_completion_date": "2014-1-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CF2A1B98-5693-4C04-9167-F85E69A88A4A",
    "patient_ID": "TCGA.HT.A61B",
    "bcr_drug_barcode": "TCGA-HT-A61B-D48470",
    "bcr_drug_uuid": "F865162E-9AF6-4DD6-9974-B16488CE6DEF",
    "form_completion_date": "2013-9-13",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77396AE6-3838-47BF-AAAE-F9A0F401EC7F",
    "patient_ID": "TCGA.HT.A61C",
    "bcr_drug_barcode": "TCGA-HT-A61C-D48457",
    "bcr_drug_uuid": "6B1BF855-0160-41D2-B553-3B5D84D7E0B1",
    "form_completion_date": "2013-11-22",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FDFF46A7-F92A-45CF-8756-6C73A406C923",
    "patient_ID": "TCGA.HT.A74H",
    "bcr_drug_barcode": "TCGA-HT-A74H-D51383",
    "bcr_drug_uuid": "FC0A8270-87F3-4552-B3F8-8F8583FB636D",
    "form_completion_date": "2013-11-18",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A3BE4E6F-C845-4D64-8111-D63FDF8CC8F1",
    "patient_ID": "TCGA.HT.A74K",
    "bcr_drug_barcode": "TCGA-HT-A74K-D65341",
    "bcr_drug_uuid": "EF15302A-0D4E-4223-A024-900520E4DC39",
    "form_completion_date": "2014-10-27",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 277,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "55a67639-ed05-4143-af96-a377bc5489ee",
    "patient_ID": "TCGA.HW.7486",
    "bcr_drug_barcode": "TCGA-HW-7486-D20186",
    "bcr_drug_uuid": "5d850c60-70ae-4855-bbff-84de40f0e806",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 6,
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D20202",
    "bcr_drug_uuid": "6d1d19fa-d658-4a97-9952-de04f72f0901",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 409,
    "drug_cycles": 12,
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "POST-OPERATIVE"
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D63125",
    "bcr_drug_uuid": "ADA2D780-8EDD-4328-9BD3-D4323E1B6739",
    "form_completion_date": "2014-7-31",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 948,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1249,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D72474",
    "bcr_drug_uuid": "824F45F9-53CE-48F8-A4D6-FAD259E3FAFD",
    "form_completion_date": "2015-7-17",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE (SULFATE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 960,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1295,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D72475",
    "bcr_drug_uuid": "D01410E1-56B4-427D-A561-FBA14BA9B356",
    "form_completion_date": "2015-7-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 960,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1236,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D72549",
    "bcr_drug_uuid": "65601EF1-0D8A-43A0-9CB4-1AB501AC127A",
    "form_completion_date": "2015-7-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1386,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1417,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D72550",
    "bcr_drug_uuid": "D635FD4C-B6F3-40B4-8CBC-609ECE0940DA",
    "form_completion_date": "2015-7-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1570,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42251e02-b687-4bf1-a1b6-e3dd978542e4",
    "patient_ID": "TCGA.HW.7487",
    "bcr_drug_barcode": "TCGA-HW-7487-D72551",
    "bcr_drug_uuid": "7D4EF79D-D7F3-4AC2-9A12-B4F0FC76E561",
    "form_completion_date": "2015-7-17",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1570,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a85fdb41-24c1-420d-8905-ec297f018bd9",
    "patient_ID": "TCGA.HW.7491",
    "bcr_drug_barcode": "TCGA-HW-7491-D35015",
    "bcr_drug_uuid": "99E72303-B1BF-46BF-8A48-3180B3E1CB46",
    "form_completion_date": "2012-9-13",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bc3b4816-df1d-44ed-a8c6-f32c8e011a1f",
    "patient_ID": "TCGA.HW.8319",
    "bcr_drug_barcode": "TCGA-HW-8319-D34779",
    "bcr_drug_uuid": "4FE29BAD-2AE2-4747-BFE9-468975720AA0",
    "form_completion_date": "2012-8-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 66,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bc3b4816-df1d-44ed-a8c6-f32c8e011a1f",
    "patient_ID": "TCGA.HW.8319",
    "bcr_drug_barcode": "TCGA-HW-8319-D34780",
    "bcr_drug_uuid": "6A4BBC1C-240E-4B7D-8F16-6D8A134AF5B7",
    "form_completion_date": "2012-8-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bc3b4816-df1d-44ed-a8c6-f32c8e011a1f",
    "patient_ID": "TCGA.HW.8319",
    "bcr_drug_barcode": "TCGA-HW-8319-D71531",
    "bcr_drug_uuid": "CB111AD6-332F-4C3D-B711-E62ADD0567B9",
    "form_completion_date": "2015-3-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1028,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1058,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bc3b4816-df1d-44ed-a8c6-f32c8e011a1f",
    "patient_ID": "TCGA.HW.8319",
    "bcr_drug_barcode": "TCGA-HW-8319-D71533",
    "bcr_drug_uuid": "4B6291A6-31E5-49D0-8852-72FFAD185089",
    "form_completion_date": "2015-3-31",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1058,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1150,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "bc3b4816-df1d-44ed-a8c6-f32c8e011a1f",
    "patient_ID": "TCGA.HW.8319",
    "bcr_drug_barcode": "TCGA-HW-8319-D71534",
    "bcr_drug_uuid": "E73AFB4E-639F-42E1-B35E-06C19A05328F",
    "form_completion_date": "2015-3-31",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1089,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1150,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e3ed0c19-6acc-4be1-aae2-73fe73cc9f24",
    "patient_ID": "TCGA.HW.8320",
    "bcr_drug_barcode": "TCGA-HW-8320-D34767",
    "bcr_drug_uuid": "BEE59C80-7266-4C1A-A9C0-6C3017ED95BA",
    "form_completion_date": "2012-8-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e3ed0c19-6acc-4be1-aae2-73fe73cc9f24",
    "patient_ID": "TCGA.HW.8320",
    "bcr_drug_barcode": "TCGA-HW-8320-D34771",
    "bcr_drug_uuid": "6CF845A9-2AC6-43D1-ABB0-C4B622F023BD",
    "form_completion_date": "2012-8-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 149,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "36cf458b-3c8e-48e7-92ab-aea1c698e417",
    "patient_ID": "TCGA.HW.8321",
    "bcr_drug_barcode": "TCGA-HW-8321-D48687",
    "bcr_drug_uuid": "39FAF97B-D0A2-4D6B-8637-1C8118F20379",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6105c037-90f1-42d9-ac38-6e2252999a64",
    "patient_ID": "TCGA.HW.8322",
    "bcr_drug_barcode": "TCGA-HW-8322-D48690",
    "bcr_drug_uuid": "D240733C-C662-4017-A526-2EA7F9A16968",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8996DC64-8C5E-4E07-8ED8-2EB11C03626B",
    "patient_ID": "TCGA.HW.A5KJ",
    "bcr_drug_barcode": "TCGA-HW-A5KJ-D48693",
    "bcr_drug_uuid": "68E1D203-9CE5-4C38-BCF7-C5CC0965C5E2",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 16,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8996DC64-8C5E-4E07-8ED8-2EB11C03626B",
    "patient_ID": "TCGA.HW.A5KJ",
    "bcr_drug_barcode": "TCGA-HW-A5KJ-D65472",
    "bcr_drug_uuid": "22481586-D92B-4036-99B4-F82F5A132DDF",
    "form_completion_date": "2014-9-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 656,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 899,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6",
    "patient_ID": "TCGA.HW.A5KK",
    "bcr_drug_barcode": "TCGA-HW-A5KK-D48696",
    "bcr_drug_uuid": "DC0EA9A7-61C9-406F-B1FD-0D3E2267F459",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A94FF28-A74D-4FE2-B9C0-06C01F0A3FB6",
    "patient_ID": "TCGA.HW.A5KK",
    "bcr_drug_barcode": "TCGA-HW-A5KK-D48698",
    "bcr_drug_uuid": "33F84057-D56D-46FB-A1CB-09F56755FEBE",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 207,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0639B753-4099-4CA4-ADB9-763069A614EF",
    "patient_ID": "TCGA.HW.A5KL",
    "bcr_drug_barcode": "TCGA-HW-A5KL-D48707",
    "bcr_drug_uuid": "BA95AA18-80DF-426E-B58A-11395CF5B384",
    "form_completion_date": "2013-9-19",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0639B753-4099-4CA4-ADB9-763069A614EF",
    "patient_ID": "TCGA.HW.A5KL",
    "bcr_drug_barcode": "TCGA-HW-A5KL-D71506",
    "bcr_drug_uuid": "CB1932E9-7E48-4908-97B0-B2A1AAF8C207",
    "form_completion_date": "2015-3-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 648,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a5f851c5-6130-4ea1-9f86-be59331a92f7",
    "patient_ID": "TCGA.IK.7675",
    "bcr_drug_barcode": "TCGA-IK-7675-D33079",
    "bcr_drug_uuid": "5622E3C6-D9EF-4F6A-98FC-980910049058",
    "form_completion_date": "2012-6-20",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 510
  },
  {
    "bcr_patient_uuid": "a5f851c5-6130-4ea1-9f86-be59331a92f7",
    "patient_ID": "TCGA.IK.7675",
    "bcr_drug_barcode": "TCGA-IK-7675-D33083",
    "bcr_drug_uuid": "1A8C1EB1-B052-4A32-AFA6-74AA05DDAF36",
    "form_completion_date": "2012-6-20",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 531,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 552
  },
  {
    "bcr_patient_uuid": "a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f",
    "patient_ID": "TCGA.IK.8125",
    "bcr_drug_barcode": "TCGA-IK-8125-D32771",
    "bcr_drug_uuid": "1c78021d-9fd1-4a52-a555-ff3f7a350d55",
    "form_completion_date": "2012-6-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a0b7c7c8-a6f2-41ba-9e61-9b7f8fbbbe1f",
    "patient_ID": "TCGA.IK.8125",
    "bcr_drug_barcode": "TCGA-IK-8125-D32772",
    "bcr_drug_uuid": "cad891ef-1404-4310-9584-2fac7a4052a7",
    "form_completion_date": "2012-6-11",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "442DF188-B678-45BB-BD9D-7071ED8AAA5A",
    "patient_ID": "TCGA.KT.A74X",
    "bcr_drug_barcode": "TCGA-KT-A74X-D55168",
    "bcr_drug_uuid": "1D267D32-E728-4D81-80CC-6F90AC480D07",
    "form_completion_date": "2013-12-30",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77472095-030D-4679-921D-8E8E217956C5",
    "patient_ID": "TCGA.KT.A7W1",
    "bcr_drug_barcode": "TCGA-KT-A7W1-D56356",
    "bcr_drug_uuid": "84F35414-A491-477D-8C80-61A307770786",
    "form_completion_date": "2014-2-3",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 61,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1F13065A-40F7-455D-B8EB-F9A128722EAC",
    "patient_ID": "TCGA.P5.A5EX",
    "bcr_drug_barcode": "TCGA-P5-A5EX-D56611",
    "bcr_drug_uuid": "8F3188FD-9D3F-4F2E-BDF9-0EC79E09DDA3",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EB5D055-E1C8-4B93-9205-A49A6E79DFD4",
    "patient_ID": "TCGA.P5.A5F0",
    "bcr_drug_barcode": "TCGA-P5-A5F0-D56613",
    "bcr_drug_uuid": "23BCC949-2852-41F4-BDAF-D4952D034C99",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EB5D055-E1C8-4B93-9205-A49A6E79DFD4",
    "patient_ID": "TCGA.P5.A5F0",
    "bcr_drug_barcode": "TCGA-P5-A5F0-D59339",
    "bcr_drug_uuid": "805459C3-71F0-4B2F-A213-299DB0870A26",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7EB5D055-E1C8-4B93-9205-A49A6E79DFD4",
    "patient_ID": "TCGA.P5.A5F0",
    "bcr_drug_barcode": "TCGA-P5-A5F0-D59340",
    "bcr_drug_uuid": "BBF4D2E7-E9D8-4C79-ABF5-15A7A8699D7C",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 287,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85FA637-941A-4A9A-8029-F5B44F3DA430",
    "patient_ID": "TCGA.P5.A5F2",
    "bcr_drug_barcode": "TCGA-P5-A5F2-D56615",
    "bcr_drug_uuid": "FEAA8647-2C75-47E9-A256-1C12969E38D6",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "MUSTOPHORAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85FA637-941A-4A9A-8029-F5B44F3DA430",
    "patient_ID": "TCGA.P5.A5F2",
    "bcr_drug_barcode": "TCGA-P5-A5F2-D59335",
    "bcr_drug_uuid": "DA5506EB-D01F-4051-92F8-13CB90678F5C",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C85FA637-941A-4A9A-8029-F5B44F3DA430",
    "patient_ID": "TCGA.P5.A5F2",
    "bcr_drug_barcode": "TCGA-P5-A5F2-D59336",
    "bcr_drug_uuid": "4EC478D5-914A-4950-A014-60C5EEA852D3",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "THEMOZOLOMIDE",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0557B788-5AED-4919-85EB-A503AD893D75",
    "patient_ID": "TCGA.P5.A5F4",
    "bcr_drug_barcode": "TCGA-P5-A5F4-D56617",
    "bcr_drug_uuid": "C4A58407-7379-4D51-A886-47543129C008",
    "form_completion_date": "2014-5-8",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0557B788-5AED-4919-85EB-A503AD893D75",
    "patient_ID": "TCGA.P5.A5F4",
    "bcr_drug_barcode": "TCGA-P5-A5F4-D59337",
    "bcr_drug_uuid": "0C98C338-FA72-4C9A-BFD2-670DEAE9811F",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0557B788-5AED-4919-85EB-A503AD893D75",
    "patient_ID": "TCGA.P5.A5F4",
    "bcr_drug_barcode": "TCGA-P5-A5F4-D59338",
    "bcr_drug_uuid": "8E938678-3A97-410C-9B50-05FB00B868A8",
    "form_completion_date": "2014-5-30",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "141F0546-F6F2-408F-AC86-07CA4AADF3D0",
    "patient_ID": "TCGA.P5.A72Z",
    "bcr_drug_barcode": "TCGA-P5-A72Z-D69022",
    "bcr_drug_uuid": "8591DB4B-A198-444D-BC08-90FEB7D6C77B",
    "form_completion_date": "2014-12-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 270,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D81B9957-8C82-4006-B111-449FA9FB95ED",
    "patient_ID": "TCGA.P5.A733",
    "bcr_drug_barcode": "TCGA-P5-A733-D69014",
    "bcr_drug_uuid": "6CFB08AB-DEA8-40DD-BF6F-4B0DE746A072",
    "form_completion_date": "2014-12-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 414,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "505E9812-D13E-42D3-AEE2-55A85D6F4551",
    "patient_ID": "TCGA.QH.A65R",
    "bcr_drug_barcode": "TCGA-QH-A65R-D46271",
    "bcr_drug_uuid": "2B190C17-1558-498E-B160-A6E7434F0D02",
    "form_completion_date": "2013-8-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AD72E61E-51E3-4992-AC77-65E895935736",
    "patient_ID": "TCGA.QH.A65V",
    "bcr_drug_barcode": "TCGA-QH-A65V-D47245",
    "bcr_drug_uuid": "C19462BC-CC29-49EA-804E-A35C6FF34868",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AD72E61E-51E3-4992-AC77-65E895935736",
    "patient_ID": "TCGA.QH.A65V",
    "bcr_drug_barcode": "TCGA-QH-A65V-D47246",
    "bcr_drug_uuid": "772815A6-D22C-478E-B754-DC60B27CFA26",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AD72E61E-51E3-4992-AC77-65E895935736",
    "patient_ID": "TCGA.QH.A65V",
    "bcr_drug_barcode": "TCGA-QH-A65V-D47248",
    "bcr_drug_uuid": "DC68F1EC-A84E-42E8-8F2E-BD8F195F5255",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "451BAD4F-6D72-4526-9978-38E090FC479F",
    "patient_ID": "TCGA.QH.A65X",
    "bcr_drug_barcode": "TCGA-QH-A65X-D52174",
    "bcr_drug_uuid": "9E786304-7510-4EEB-ADD4-8C590CD16794",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 139,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "451BAD4F-6D72-4526-9978-38E090FC479F",
    "patient_ID": "TCGA.QH.A65X",
    "bcr_drug_barcode": "TCGA-QH-A65X-D52175",
    "bcr_drug_uuid": "BF362E39-FE1C-434A-9BD5-55034EA1D3AD",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "451BAD4F-6D72-4526-9978-38E090FC479F",
    "patient_ID": "TCGA.QH.A65X",
    "bcr_drug_barcode": "TCGA-QH-A65X-D52178",
    "bcr_drug_uuid": "10F66F83-C03E-485A-8660-EBB562767B40",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "451BAD4F-6D72-4526-9978-38E090FC479F",
    "patient_ID": "TCGA.QH.A65X",
    "bcr_drug_barcode": "TCGA-QH-A65X-D52179",
    "bcr_drug_uuid": "B81F99CB-649A-436E-B7B9-76FA0AA133B6",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 365,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C2F9DFF7-751B-4704-8E6E-F4F800297030",
    "patient_ID": "TCGA.QH.A65Z",
    "bcr_drug_barcode": "TCGA-QH-A65Z-D47242",
    "bcr_drug_uuid": "417D497C-BAB9-4E2D-8ADC-CAB6A66993E8",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C2F9DFF7-751B-4704-8E6E-F4F800297030",
    "patient_ID": "TCGA.QH.A65Z",
    "bcr_drug_barcode": "TCGA-QH-A65Z-D47233",
    "bcr_drug_uuid": "BEB98A3B-70E9-4079-AB18-C75B959D1697",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C2F9DFF7-751B-4704-8E6E-F4F800297030",
    "patient_ID": "TCGA.QH.A65Z",
    "bcr_drug_barcode": "TCGA-QH-A65Z-D47227",
    "bcr_drug_uuid": "035258F9-5274-43D9-ADF6-ECE0403B8F97",
    "form_completion_date": "2013-8-29",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 315,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D17C327-435A-4CBA-9626-3B5B7B7375BB",
    "patient_ID": "TCGA.QH.A6CS",
    "bcr_drug_barcode": "TCGA-QH-A6CS-D46344",
    "bcr_drug_uuid": "E9963102-9F44-402A-AB06-9BD4490D1441",
    "form_completion_date": "2013-8-7",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 423,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D17C327-435A-4CBA-9626-3B5B7B7375BB",
    "patient_ID": "TCGA.QH.A6CS",
    "bcr_drug_barcode": "TCGA-QH-A6CS-D67861",
    "bcr_drug_uuid": "44465574-74DD-4C53-B1AE-CC241D2CD651",
    "form_completion_date": "2014-11-13",
    "pharmaceutical_therapy_drug_name": "FOTEMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76CB16F9-37BE-450E-B60A-5F0D0F1EC2BC",
    "patient_ID": "TCGA.QH.A6CU",
    "bcr_drug_barcode": "TCGA-QH-A6CU-D60340",
    "bcr_drug_uuid": "E0569F74-EC61-4BA1-9A60-F39D2FD52391",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1758D75-B2A0-4386-BD72-6B2421D4DA6B",
    "patient_ID": "TCGA.QH.A6CY",
    "bcr_drug_barcode": "TCGA-QH-A6CY-D60334",
    "bcr_drug_uuid": "670A7D1B-F8D3-4443-A785-8AE6F79B769F",
    "form_completion_date": "2014-6-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 267,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "976D067B-9D7F-4920-A04D-E831EDC6C2C2",
    "patient_ID": "TCGA.QH.A6X4",
    "bcr_drug_barcode": "TCGA-QH-A6X4-D52186",
    "bcr_drug_uuid": "66530FFA-1EDB-4819-9F1D-22E7BD5BAC7E",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 196,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 342,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D209CFFC-FE21-4AE7-B610-E5668EA84A3B",
    "patient_ID": "TCGA.QH.A6X8",
    "bcr_drug_barcode": "TCGA-QH-A6X8-D52189",
    "bcr_drug_uuid": "024FC6C6-A023-4C1A-B135-9288BDD54730",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62088274-A45B-4616-B086-B0DDD64895F0",
    "patient_ID": "TCGA.QH.A6XC",
    "bcr_drug_barcode": "TCGA-QH-A6XC-D52192",
    "bcr_drug_uuid": "F6A33868-3D93-44CE-9CA8-270A5FCBAE74",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 390,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62088274-A45B-4616-B086-B0DDD64895F0",
    "patient_ID": "TCGA.QH.A6XC",
    "bcr_drug_barcode": "TCGA-QH-A6XC-D67825",
    "bcr_drug_uuid": "0B0F408C-2A81-4F43-9CA1-6DF6838B52BA",
    "form_completion_date": "2014-11-12",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62088274-A45B-4616-B086-B0DDD64895F0",
    "patient_ID": "TCGA.QH.A6XC",
    "bcr_drug_barcode": "TCGA-QH-A6XC-D67826",
    "bcr_drug_uuid": "E8EBF11C-6633-4A34-AD2D-8A4C8D6E8267",
    "form_completion_date": "2014-11-12",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "62088274-A45B-4616-B086-B0DDD64895F0",
    "patient_ID": "TCGA.QH.A6XC",
    "bcr_drug_barcode": "TCGA-QH-A6XC-D67827",
    "bcr_drug_uuid": "F36FD59C-5D66-49E0-B8A1-7F5EED1D5496",
    "form_completion_date": "2014-11-12",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "345D975C-E666-4614-81EB-5CCBB5BD2CF7",
    "patient_ID": "TCGA.QH.A870",
    "bcr_drug_barcode": "TCGA-QH-A870-D68241",
    "bcr_drug_uuid": "17ABE603-39E5-415F-B81D-B29E52C111BC",
    "form_completion_date": "2014-11-14",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 396,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41E4DC71-7767-44C2-9D38-110DCD37B451",
    "patient_ID": "TCGA.S9.A6TS",
    "bcr_drug_barcode": "TCGA-S9-A6TS-D51943",
    "bcr_drug_uuid": "7263A8F3-DF15-43AC-AFFB-AFC300FD85C3",
    "form_completion_date": "2013-11-26",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1697,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41E4DC71-7767-44C2-9D38-110DCD37B451",
    "patient_ID": "TCGA.S9.A6TS",
    "bcr_drug_barcode": "TCGA-S9-A6TS-D51942",
    "bcr_drug_uuid": "58259028-B8FE-40C9-81C8-A5710FB35B17",
    "form_completion_date": "2013-11-26",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1603,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "41E4DC71-7767-44C2-9D38-110DCD37B451",
    "patient_ID": "TCGA.S9.A6TS",
    "bcr_drug_barcode": "TCGA-S9-A6TS-D51944",
    "bcr_drug_uuid": "2130E3E9-86B7-4792-ABF1-36699EE70C58",
    "form_completion_date": "2013-11-26",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1704,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1859,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "048056CD-39DD-4134-A58B-70BEBB3DD2FF",
    "patient_ID": "TCGA.S9.A6TV",
    "bcr_drug_barcode": "TCGA-S9-A6TV-D54120",
    "bcr_drug_uuid": "D2063D3F-C321-44EF-97BF-4C2A2430F264",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C45E02E5-7E3C-4F36-8B8D-F54617E8A436",
    "patient_ID": "TCGA.S9.A6TW",
    "bcr_drug_barcode": "TCGA-S9-A6TW-D54121",
    "bcr_drug_uuid": "CE62E6FD-96CE-4050-999D-5D133BB1CA4D",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "432FE4A9-2CDC-4323-AFF0-59E2FDEDA194",
    "patient_ID": "TCGA.S9.A6TX",
    "bcr_drug_barcode": "TCGA-S9-A6TX-D54122",
    "bcr_drug_uuid": "79C328DC-965E-4B79-BE0D-C28DC492D171",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 856,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DCBBACA6-A24B-4BED-95DE-314CFF71E436",
    "patient_ID": "TCGA.S9.A6TY",
    "bcr_drug_barcode": "TCGA-S9-A6TY-D54129",
    "bcr_drug_uuid": "B9AD9F54-7C56-4194-9F81-5B8774E9E3A2",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A343FBE3-147A-4656-9E90-5408298CA12C",
    "patient_ID": "TCGA.S9.A6U0",
    "bcr_drug_barcode": "TCGA-S9-A6U0-D54135",
    "bcr_drug_uuid": "E8308CBE-67F1-4074-B091-5B632DC7B1E5",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A343FBE3-147A-4656-9E90-5408298CA12C",
    "patient_ID": "TCGA.S9.A6U0",
    "bcr_drug_barcode": "TCGA-S9-A6U0-D54136",
    "bcr_drug_uuid": "DB7B276C-FD50-475A-B68F-9974D22DFA38",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A343FBE3-147A-4656-9E90-5408298CA12C",
    "patient_ID": "TCGA.S9.A6U0",
    "bcr_drug_barcode": "TCGA-S9-A6U0-D65506",
    "bcr_drug_uuid": "61FB2564-39E2-4F0F-B0B7-BE0E4D4F4ACD",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 698,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A343FBE3-147A-4656-9E90-5408298CA12C",
    "patient_ID": "TCGA.S9.A6U0",
    "bcr_drug_barcode": "TCGA-S9-A6U0-D70003",
    "bcr_drug_uuid": "75759921-173C-42B8-9F23-1ED2D3FA32FC",
    "form_completion_date": "2015-1-26",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A343FBE3-147A-4656-9E90-5408298CA12C",
    "patient_ID": "TCGA.S9.A6U0",
    "bcr_drug_barcode": "TCGA-S9-A6U0-D70005",
    "bcr_drug_uuid": "DE7BF179-1B4B-4870-AFA3-F954B842FD71",
    "form_completion_date": "2015-1-26",
    "pharmaceutical_therapy_drug_name": "TENIPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A5E10E2E-5157-487B-88DC-6C70AD5E244A",
    "patient_ID": "TCGA.S9.A6U1",
    "bcr_drug_barcode": "TCGA-S9-A6U1-D54137",
    "bcr_drug_uuid": "DAF6DEBA-5874-4702-8C90-D11C9A811963",
    "form_completion_date": "2013-12-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B10A9314-FD40-459E-97EA-AFFC636DCEEA",
    "patient_ID": "TCGA.S9.A6U8",
    "bcr_drug_barcode": "TCGA-S9-A6U8-D65503",
    "bcr_drug_uuid": "DA2DA54A-C52B-49DE-8153-D1D2207C107D",
    "form_completion_date": "2014-9-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2832,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2988,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B10A9314-FD40-459E-97EA-AFFC636DCEEA",
    "patient_ID": "TCGA.S9.A6U8",
    "bcr_drug_barcode": "TCGA-S9-A6U8-D67329",
    "bcr_drug_uuid": "A70CE6B1-C8BE-460D-9896-3B76422807D9",
    "form_completion_date": "2014-11-4",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2200,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B10A9314-FD40-459E-97EA-AFFC636DCEEA",
    "patient_ID": "TCGA.S9.A6U8",
    "bcr_drug_barcode": "TCGA-S9-A6U8-D67331",
    "bcr_drug_uuid": "01F378FF-08BF-4C09-940D-608E205273E1",
    "form_completion_date": "2014-11-4",
    "pharmaceutical_therapy_drug_name": "CARMUSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2720,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2762,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B10A9314-FD40-459E-97EA-AFFC636DCEEA",
    "patient_ID": "TCGA.S9.A6U8",
    "bcr_drug_barcode": "TCGA-S9-A6U8-D67333",
    "bcr_drug_uuid": "50DE2066-0076-475B-9024-2CB0E175992A",
    "form_completion_date": "2014-11-4",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2787,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2794,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3E4851CA-4D69-4035-A2DD-8ED6E70F1FFB",
    "patient_ID": "TCGA.S9.A6WD",
    "bcr_drug_barcode": "TCGA-S9-A6WD-D54273",
    "bcr_drug_uuid": "ABFA8D57-5DAF-4AB3-A26C-A1C0BD804AF3",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 322,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D2C49C3-0721-4BD2-B39F-7872F2DE996D",
    "patient_ID": "TCGA.S9.A6WE",
    "bcr_drug_barcode": "TCGA-S9-A6WE-D54274",
    "bcr_drug_uuid": "E164A769-7AB9-4E57-BC46-B974EFBE174A",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A1192DF3-7667-4D1E-A1A0-79F6CC827DCF",
    "patient_ID": "TCGA.S9.A6WG",
    "bcr_drug_barcode": "TCGA-S9-A6WG-D54278",
    "bcr_drug_uuid": "E826C6BB-BE8F-47ED-AB58-889FA1450494",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F79420CA-B0AE-417C-95F7-D28C35760202",
    "patient_ID": "TCGA.S9.A6WM",
    "bcr_drug_barcode": "TCGA-S9-A6WM-D54283",
    "bcr_drug_uuid": "E04F54CA-4188-438B-9469-AE68951B6396",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F79420CA-B0AE-417C-95F7-D28C35760202",
    "patient_ID": "TCGA.S9.A6WM",
    "bcr_drug_barcode": "TCGA-S9-A6WM-D63844",
    "bcr_drug_uuid": "4636DEAC-D69D-4A41-BD2A-2CEFFC48A682",
    "form_completion_date": "2014-8-20",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 524,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A418FE65-DFDD-4C84-B27C-B4567B50F457",
    "patient_ID": "TCGA.S9.A6WN",
    "bcr_drug_barcode": "TCGA-S9-A6WN-D54288",
    "bcr_drug_uuid": "0189105C-BCD7-4A93-8747-EB4C23CA296B",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A418FE65-DFDD-4C84-B27C-B4567B50F457",
    "patient_ID": "TCGA.S9.A6WN",
    "bcr_drug_barcode": "TCGA-S9-A6WN-D63848",
    "bcr_drug_uuid": "0D76F957-E4A4-48D7-91B5-14980A6F3A20",
    "form_completion_date": "2014-8-20",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 425,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 805,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A418FE65-DFDD-4C84-B27C-B4567B50F457",
    "patient_ID": "TCGA.S9.A6WN",
    "bcr_drug_barcode": "TCGA-S9-A6WN-D72372",
    "bcr_drug_uuid": "337FAAFA-E3B9-46CE-B37C-AB322DA11444",
    "form_completion_date": "2015-6-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 317,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A418FE65-DFDD-4C84-B27C-B4567B50F457",
    "patient_ID": "TCGA.S9.A6WN",
    "bcr_drug_barcode": "TCGA-S9-A6WN-D72373",
    "bcr_drug_uuid": "370B1B75-B283-4BF7-AD4C-7853B4A9F2E9",
    "form_completion_date": "2015-6-9",
    "pharmaceutical_therapy_drug_name": "LOMUSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 679,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 805,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A418FE65-DFDD-4C84-B27C-B4567B50F457",
    "patient_ID": "TCGA.S9.A6WN",
    "bcr_drug_barcode": "TCGA-S9-A6WN-D72375",
    "bcr_drug_uuid": "FFB8E833-2183-4A3F-ABB5-93C24C7B929B",
    "form_completion_date": "2015-6-9",
    "pharmaceutical_therapy_drug_name": "PEMBROLIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 846,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "081B6532-0ED4-445A-BECB-CB2290F4854D",
    "patient_ID": "TCGA.S9.A6WP",
    "bcr_drug_barcode": "TCGA-S9-A6WP-D54293",
    "bcr_drug_uuid": "95562946-2EC2-4DDA-87DE-5B8D4C2C3840",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A80B0FAB-6189-497F-997F-77234B69179C",
    "patient_ID": "TCGA.S9.A7IX",
    "bcr_drug_barcode": "TCGA-S9-A7IX-D54298",
    "bcr_drug_uuid": "9A786DDE-D06C-4F38-98FE-C4CF7D576A4A",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A80B0FAB-6189-497F-997F-77234B69179C",
    "patient_ID": "TCGA.S9.A7IX",
    "bcr_drug_barcode": "TCGA-S9-A7IX-D54301",
    "bcr_drug_uuid": "905CDC2A-789D-490F-9D2B-47831F8930B5",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 437,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 470,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A80B0FAB-6189-497F-997F-77234B69179C",
    "patient_ID": "TCGA.S9.A7IX",
    "bcr_drug_barcode": "TCGA-S9-A7IX-D55835",
    "bcr_drug_uuid": "01CF6350-DFBA-43D6-B405-ACA07C137AC2",
    "form_completion_date": "2014-1-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 413,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A80B0FAB-6189-497F-997F-77234B69179C",
    "patient_ID": "TCGA.S9.A7IX",
    "bcr_drug_barcode": "TCGA-S9-A7IX-D72343",
    "bcr_drug_uuid": "F7CA28FD-A3F2-4A7A-86CC-6AFC4C01F159",
    "form_completion_date": "2015-5-27",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 589,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 640,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94B95C07-5F70-4A1B-B40F-DC13F6A160D5",
    "patient_ID": "TCGA.S9.A7IY",
    "bcr_drug_barcode": "TCGA-S9-A7IY-D54303",
    "bcr_drug_uuid": "AF8DF137-6656-4FF2-92A9-67F97531CC73",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94B95C07-5F70-4A1B-B40F-DC13F6A160D5",
    "patient_ID": "TCGA.S9.A7IY",
    "bcr_drug_barcode": "TCGA-S9-A7IY-D55868",
    "bcr_drug_uuid": "1C2108F9-CDE5-4A43-8E7B-0965A28A76C0",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94B95C07-5F70-4A1B-B40F-DC13F6A160D5",
    "patient_ID": "TCGA.S9.A7IY",
    "bcr_drug_barcode": "TCGA-S9-A7IY-D55869",
    "bcr_drug_uuid": "4A8E784C-9AEA-416A-8597-E7C7FE05DA0C",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01A13ABA-74A4-4895-A5AD-E5119925C202",
    "patient_ID": "TCGA.S9.A7IZ",
    "bcr_drug_barcode": "TCGA-S9-A7IZ-D69999",
    "bcr_drug_uuid": "B9C4EB70-267B-4314-9FE4-2BFE19D7C031",
    "form_completion_date": "2015-1-26",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "01A13ABA-74A4-4895-A5AD-E5119925C202",
    "patient_ID": "TCGA.S9.A7IZ",
    "bcr_drug_barcode": "TCGA-S9-A7IZ-D70000",
    "bcr_drug_uuid": "DDFDB90E-229B-4832-9BC3-6F0B2284E684",
    "form_completion_date": "2015-1-26",
    "pharmaceutical_therapy_drug_name": "TENIPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing_indicator": true,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6A8241A8-D9EE-414B-89FD-4C3B9F181CC7",
    "patient_ID": "TCGA.S9.A7J0",
    "bcr_drug_barcode": "TCGA-S9-A7J0-D54307",
    "bcr_drug_uuid": "DA526546-EB02-46C7-B69F-63AC4DFD56AA",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6A8241A8-D9EE-414B-89FD-4C3B9F181CC7",
    "patient_ID": "TCGA.S9.A7J0",
    "bcr_drug_barcode": "TCGA-S9-A7J0-D54310",
    "bcr_drug_uuid": "C9C5DF99-F530-4B6D-9195-CC37B9204FBD",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6A8241A8-D9EE-414B-89FD-4C3B9F181CC7",
    "patient_ID": "TCGA.S9.A7J0",
    "bcr_drug_barcode": "TCGA-S9-A7J0-D65753",
    "bcr_drug_uuid": "421479EA-E7D1-4071-8BBD-540D82CB1276",
    "form_completion_date": "2014-9-30",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6A8241A8-D9EE-414B-89FD-4C3B9F181CC7",
    "patient_ID": "TCGA.S9.A7J0",
    "bcr_drug_barcode": "TCGA-S9-A7J0-D65754",
    "bcr_drug_uuid": "A5356BD0-A2E0-4228-9FC0-DA26B028EAA5",
    "form_completion_date": "2014-9-30",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 490,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6A8241A8-D9EE-414B-89FD-4C3B9F181CC7",
    "patient_ID": "TCGA.S9.A7J0",
    "bcr_drug_barcode": "TCGA-S9-A7J0-D72437",
    "bcr_drug_uuid": "8AE0AFC4-FBE5-4DE9-B572-FE5E5E766EDA",
    "form_completion_date": "2015-6-16",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "194E8231-E8D4-477F-8C62-E11F2484ECCE",
    "patient_ID": "TCGA.S9.A7J2",
    "bcr_drug_barcode": "TCGA-S9-A7J2-D54313",
    "bcr_drug_uuid": "6C6D2716-FE6F-46D4-9E96-4D71B6C39880",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "194E8231-E8D4-477F-8C62-E11F2484ECCE",
    "patient_ID": "TCGA.S9.A7J2",
    "bcr_drug_barcode": "TCGA-S9-A7J2-D55870",
    "bcr_drug_uuid": "37EB9F05-E168-4FD1-9867-222ABCFCA522",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "194E8231-E8D4-477F-8C62-E11F2484ECCE",
    "patient_ID": "TCGA.S9.A7J2",
    "bcr_drug_barcode": "TCGA-S9-A7J2-D55871",
    "bcr_drug_uuid": "F5C63655-7238-45FE-9889-E99852633505",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "032096A6-1923-44B9-A1CB-181BED041C8E",
    "patient_ID": "TCGA.S9.A7J3",
    "bcr_drug_barcode": "TCGA-S9-A7J3-D54317",
    "bcr_drug_uuid": "340DB40F-BC8C-4491-97EB-77052E2774E2",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "032096A6-1923-44B9-A1CB-181BED041C8E",
    "patient_ID": "TCGA.S9.A7J3",
    "bcr_drug_barcode": "TCGA-S9-A7J3-D55872",
    "bcr_drug_uuid": "AA5936A5-5DA4-4CD8-8BB0-B78072DC246F",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "032096A6-1923-44B9-A1CB-181BED041C8E",
    "patient_ID": "TCGA.S9.A7J3",
    "bcr_drug_barcode": "TCGA-S9-A7J3-D55873",
    "bcr_drug_uuid": "66B33756-4A29-4BFE-953E-AAB81C2A11F5",
    "form_completion_date": "2014-1-17",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "765588AA-075F-477F-9C18-099D018D3A1B",
    "patient_ID": "TCGA.S9.A7QW",
    "bcr_drug_barcode": "TCGA-S9-A7QW-D66224",
    "bcr_drug_uuid": "8B394C53-188F-4E7E-A814-51B27B3B1898",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 592,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "427F4D23-2B76-4A2A-A498-0C3473F57169",
    "patient_ID": "TCGA.S9.A7QX",
    "bcr_drug_barcode": "TCGA-S9-A7QX-D52660",
    "bcr_drug_uuid": "B1D7F4E1-8C4A-4A4E-8A0B-0A59C9CFDF41",
    "form_completion_date": "2013-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94A2FF09-F7AC-4AEA-A2B2-0DC1B82AE635",
    "patient_ID": "TCGA.S9.A7QY",
    "bcr_drug_barcode": "TCGA-S9-A7QY-D52662",
    "bcr_drug_uuid": "18543B64-497C-49FA-A339-DE4E5F196698",
    "form_completion_date": "2013-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 372,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "78A212BC-A740-46BF-A10D-0B9809A5BB3F",
    "patient_ID": "TCGA.S9.A7R1",
    "bcr_drug_barcode": "TCGA-S9-A7R1-D52667",
    "bcr_drug_uuid": "5BFE8996-358E-4F43-9550-08E976624A6C",
    "form_completion_date": "2013-12-5",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3801,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3835,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58650D08-7685-41DE-9AE0-21665F8F449F",
    "patient_ID": "TCGA.S9.A7R4",
    "bcr_drug_barcode": "TCGA-S9-A7R4-D53375",
    "bcr_drug_uuid": "E79715B3-C0A5-477E-B0D5-63850FCF96B2",
    "form_completion_date": "2013-12-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F",
    "patient_ID": "TCGA.S9.A7R7",
    "bcr_drug_barcode": "TCGA-S9-A7R7-D54335",
    "bcr_drug_uuid": "C0C32C24-B274-471E-80F8-E7962685C779",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 526,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F",
    "patient_ID": "TCGA.S9.A7R7",
    "bcr_drug_barcode": "TCGA-S9-A7R7-D54336",
    "bcr_drug_uuid": "86FE680F-EC70-47BB-A988-C5653F3519F8",
    "form_completion_date": "2013-12-18",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 716,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1095,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6975EB0-CFA6-4B7A-BBE4-72BBDD3D3B6F",
    "patient_ID": "TCGA.S9.A7R7",
    "bcr_drug_barcode": "TCGA-S9-A7R7-D66256",
    "bcr_drug_uuid": "C5D00225-BD0E-449C-B3C8-EFB43706B949",
    "form_completion_date": "2014-10-7",
    "pharmaceutical_therapy_drug_name": "CARMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2720,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2847,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7883E417-A793-4614-9528-6C2E9E44379F",
    "patient_ID": "TCGA.S9.A7R8",
    "bcr_drug_barcode": "TCGA-S9-A7R8-D53396",
    "bcr_drug_uuid": "0036ABAB-DE64-4562-AEED-BD2BD67FA6CE",
    "form_completion_date": "2013-12-11",
    "pharmaceutical_therapy_drug_name": "TEMOZOLAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 771,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 786,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7883E417-A793-4614-9528-6C2E9E44379F",
    "patient_ID": "TCGA.S9.A7R8",
    "bcr_drug_barcode": "TCGA-S9-A7R8-D53398",
    "bcr_drug_uuid": "953AA7F0-A050-4742-826F-20A6C094BC2C",
    "form_completion_date": "2013-12-11",
    "pharmaceutical_therapy_drug_name": "NIMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 803,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 925,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C4F522C9-BFF5-4899-8D27-C105DAB795A9",
    "patient_ID": "TCGA.S9.A89V",
    "bcr_drug_barcode": "TCGA-S9-A89V-D55979",
    "bcr_drug_uuid": "5E019CFD-373C-4B12-BEF4-3C1D3B482A9B",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 46,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C4F522C9-BFF5-4899-8D27-C105DAB795A9",
    "patient_ID": "TCGA.S9.A89V",
    "bcr_drug_barcode": "TCGA-S9-A89V-D55980",
    "bcr_drug_uuid": "BB815198-62A3-4438-8B48-CC0D406E897A",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CC8614C4-D535-4AD9-82F0-F4DC7AD11D0F",
    "patient_ID": "TCGA.S9.A89Z",
    "bcr_drug_barcode": "TCGA-S9-A89Z-D55988",
    "bcr_drug_uuid": "B5AC47E4-BDB2-40EC-8E75-8E0B6BBAF37A",
    "form_completion_date": "2014-1-23",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D13AC936-87A9-4164-BDAB-02CCF3908CFE",
    "patient_ID": "TCGA.TM.A7C3",
    "bcr_drug_barcode": "TCGA-TM-A7C3-D52932",
    "bcr_drug_uuid": "8BF19BF0-DF98-4865-9F48-EFFCAB78B2A5",
    "form_completion_date": "2013-12-9",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 748,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EE6BF12F-8A73-49E2-B566-368B2B42165B",
    "patient_ID": "TCGA.TM.A84B",
    "bcr_drug_barcode": "TCGA-TM-A84B-D56640",
    "bcr_drug_uuid": "9FE9D101-9718-4241-B3BC-6459C9570FF0",
    "form_completion_date": "2014-2-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 188,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8643437F-CD1B-47C8-86BD-87B6C2F80747",
    "patient_ID": "TCGA.TM.A84C",
    "bcr_drug_barcode": "TCGA-TM-A84C-D56641",
    "bcr_drug_uuid": "315CD50A-7BFA-4B52-8B0F-126DDC841902",
    "form_completion_date": "2014-2-16",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 297,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 459,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF",
    "patient_ID": "TCGA.TM.A84J",
    "bcr_drug_barcode": "TCGA-TM-A84J-D56500",
    "bcr_drug_uuid": "CD42B16D-E498-41D9-8798-158E92B765DD",
    "form_completion_date": "2014-2-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B3720405-CE3F-49C7-A5D9-BBFFD06F6AEF",
    "patient_ID": "TCGA.TM.A84J",
    "bcr_drug_barcode": "TCGA-TM-A84J-D56501",
    "bcr_drug_uuid": "083ACA4E-16F2-4700-9A59-61D762064443",
    "form_completion_date": "2014-2-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 476,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9B161C41-4F76-4ED1-B60F-2B093BC70EDB",
    "patient_ID": "TCGA.TM.A84L",
    "bcr_drug_barcode": "TCGA-TM-A84L-D56507",
    "bcr_drug_uuid": "E0E255CD-36AF-4A3B-8243-7A9B7A8F9521",
    "form_completion_date": "2014-2-17",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1066,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1185,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61FF31A4-4FDC-476C-B456-2A2FED4BAE6B",
    "patient_ID": "TCGA.TM.A84M",
    "bcr_drug_barcode": "TCGA-TM-A84M-D56522",
    "bcr_drug_uuid": "796B3758-7F92-49E4-8FAB-5AF004C37379",
    "form_completion_date": "2014-2-17",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61FF31A4-4FDC-476C-B456-2A2FED4BAE6B",
    "patient_ID": "TCGA.TM.A84M",
    "bcr_drug_barcode": "TCGA-TM-A84M-D58912",
    "bcr_drug_uuid": "B8E667B8-9536-4B24-9BD6-5E4A8C662574",
    "form_completion_date": "2014-4-28",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE (CCNU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "61FF31A4-4FDC-476C-B456-2A2FED4BAE6B",
    "patient_ID": "TCGA.TM.A84M",
    "bcr_drug_barcode": "TCGA-TM-A84M-D58913",
    "bcr_drug_uuid": "12389314-83EC-4478-B017-CBE512918876",
    "form_completion_date": "2014-4-28",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 138,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 264,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A66A3847-7570-4486-8845-86B6125104A2",
    "patient_ID": "TCGA.VM.A8C8",
    "bcr_drug_barcode": "TCGA-VM-A8C8-D66844",
    "bcr_drug_uuid": "AD48C107-E4BE-4D61-947F-A3A66DFAD1AB",
    "form_completion_date": "2014-10-24",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1282,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1431,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDD1FD4C-3427-496C-8391-4AEB6730D3CC",
    "patient_ID": "TCGA.VM.A8CA",
    "bcr_drug_barcode": "TCGA-VM-A8CA-D56923",
    "bcr_drug_uuid": "D67720C8-8514-4D9F-9DF3-1F6C30C595DC",
    "form_completion_date": "2014-2-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 373,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66C52A31-6503-40B5-A55E-FA476EAF0567",
    "patient_ID": "TCGA.VM.A8CE",
    "bcr_drug_barcode": "TCGA-VM-A8CE-D56930",
    "bcr_drug_uuid": "AA881940-C510-48F7-B6A4-15DEB63B47FD",
    "form_completion_date": "2014-2-26",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 349,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66C52A31-6503-40B5-A55E-FA476EAF0567",
    "patient_ID": "TCGA.VM.A8CE",
    "bcr_drug_barcode": "TCGA-VM-A8CE-D66855",
    "bcr_drug_uuid": "9B5668CC-DC75-4156-A200-F5D027115874",
    "form_completion_date": "2014-10-24",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 925,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 986,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66C52A31-6503-40B5-A55E-FA476EAF0567",
    "patient_ID": "TCGA.VM.A8CE",
    "bcr_drug_barcode": "TCGA-VM-A8CE-D66856",
    "bcr_drug_uuid": "8D5F8F37-1A60-4079-8E31-EE3323D7B2C6",
    "form_completion_date": "2014-10-24",
    "pharmaceutical_therapy_drug_name": "PROCARBAZINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 898,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66C52A31-6503-40B5-A55E-FA476EAF0567",
    "patient_ID": "TCGA.VM.A8CE",
    "bcr_drug_barcode": "TCGA-VM-A8CE-D66854",
    "bcr_drug_uuid": "E095025B-7F6F-428B-9E8F-DF83D17C946F",
    "form_completion_date": "2014-11-19",
    "pharmaceutical_therapy_drug_name": "LOMUSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 918,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0073A136-D5F4-4FD6-88F9-711768F2ABC6",
    "patient_ID": "TCGA.VM.A8CF",
    "bcr_drug_barcode": "TCGA-VM-A8CF-D56941",
    "bcr_drug_uuid": "6AF8B596-1900-4064-83A0-438EF1CC6731",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "10887E42-444D-49FC-AEE5-DD0E9FC4EA54",
    "patient_ID": "TCGA.VV.A829",
    "bcr_drug_barcode": "TCGA-VV-A829-D57959",
    "bcr_drug_uuid": "F31E4A15-F92E-476B-9296-0AE75CCA7F75",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 792,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "284680B2-F961-402D-8740-E5F9E4FB4A98",
    "patient_ID": "TCGA.VV.A86M",
    "bcr_drug_barcode": "TCGA-VV-A86M-D57956",
    "bcr_drug_uuid": "4FB2666B-CE05-4669-AF85-AE4DB466E4E0",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2C982CFB-4112-4E27-8293-25AA9E01FAAE",
    "patient_ID": "TCGA.VW.A7QS",
    "bcr_drug_barcode": "TCGA-VW-A7QS-D60049",
    "bcr_drug_uuid": "DBE5F77E-696B-49A2-B02B-31A1ACD8F5F0",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4FB16AEE-DF08-441A-846B-558E0EFE8342",
    "patient_ID": "TCGA.VW.A8FI",
    "bcr_drug_barcode": "TCGA-VW-A8FI-D57346",
    "bcr_drug_uuid": "C5A6EC5D-6923-4747-B936-BDD1F1B6EEA3",
    "form_completion_date": "2014-3-10",
    "pharmaceutical_therapy_drug_name": "TEMOZOLOMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42156C6A-416E-4832-9C95-CEE6084B0910",
    "patient_ID": "TCGA.WH.A86K",
    "bcr_drug_barcode": "TCGA-WH-A86K-D55918",
    "bcr_drug_uuid": "0EA6C53F-4009-49B6-A854-8D10B5F7F352",
    "form_completion_date": "2014-1-20",
    "pharmaceutical_therapy_drug_name": "TEMODAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
